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Summary 
 
 
Objects with complex shape and functions have always attracted attention and 
interest. The morphological diversity and complexity of naturally occurring forms and 
patterns have been a motivation for humans to copy and adopt ideas from Nature to 
achieve functional, aesthetic and social value. 
Biomimetics is addressed to the design and development of new synthetic materials 
using strategies adopted by living organisms to produce biological materials. In 
particular, biomineralized tissues are often sophisticate composite materials, in which 
the components and the interfaces between them have been defined and optimized, and 
that present unusual and optimal chemical-physical, morphological and mechanical 
properties. Moreover, biominerals are generally produced by easily traceable raw 
materials, in aqueous media and at room pressure and temperature, that is through cheap 
process and materials. Thus, it is not surprising that the idea to mimic those strategies 
proper of Nature has been employed in several areas of applied sciences, such as for the 
preparation of liquid crystals, ceramic thin films computer switches and many other 
advanced materials. 
 
On this basis, this PhD thesis is focused on the investigation of the interaction of 
biologically active ions and molecules with calcium phosphates with the aim to develop 
new materials for the substitution and repair of skeletal tissue, according to the 
following lines: 
 
I. Modified calcium phosphates. 
 
A relevant part of this PhD thesis has been addressed to study the interaction of 
Strontium with calcium phosphates. It was demonstrated that strontium ion can 
substitute for calcium into hydroxyapatite, causing appreciable structural and 
morphological modifications. The detailed structural analysis carried out on the 
nanocrystals at different strontium content provided new insight into its interaction with 
the structure of hydroxyapatite. 
At variance with the behaviour of Sr towards HA, it was found that this ion inhibits 
the synthesis of octacalcium phosphate. However, it can substitute for calcium in this 
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structure up to 15 atom %, in agreement with the increase of the cell parameters 
observed on increasing ion concentration. A similar behaviour was found for 
Magnesium ion, whereas Manganese inhibits the synthesis of octacalcium phosphate 
and it promotes the precipitation of dicalcium phosphate dehydrate. 
It was also found that Strontium affects the kinetics of the reaction of hydrolysis of -
TCP. It inhibits the conversion from -TCP to hydroxyapatite. However, the resulting 
apatitic phase contains significant amounts of Sr2+ suggesting that the addition of Sr2+ to 
the composition of -TCP bone cements could be successfully exploited for its local 
delivery in bone defects. 
The hydrolysis of -TCP has been investigated also in the presence of increasing 
amounts of gelatin: the results indicated that this biopolymer accelerates the hydrolysis 
reaction and promotes the conversion of -TCP into OCP, suggesting that its addition in 
the composition of calcium phosphate cements can be employed to modulate the 
OCP/HA ratio, and as a consequence the solubility, of the set cement. 
 
II. Deposition of modified calcium phosphates on metallic substrates. 
 
Coating with a thin film of calcium phosphates is frequently applied on the surface of 
metallic implants in order to combine the high mechanical strength of the metal with the 
excellent bioactivity of the calcium phosphates surface layers. During this PhD thesis, 
thank to the collaboration with prof. I.N. Mihailescu, head of the Laser-Surface-Plasma 
Interactions Laboratory (National Institute for Lasers, Plasma and Radiation Physics – 
Laser Department, Bucharest) Pulsed Laser Deposition has been successfully applied to 
deposit thin films of Sr substituted HA on Titanium substrates. The synthesized coatings 
displayed a uniform Sr distribution, a granular surface and a good degree of crystallinity 
which slightly decreased on increasing Sr content. The results of in vitro tests carried 
out on osteoblast-like and osteoclast cells suggested that the presence of Sr in HA thin 
films can enhance the positive effect of HA coatings on osteointegration and bone 
regeneration, and prevent undesirable bone resorption. 
The possibility to introduce an active molecule in the implant site was explored using 
Matrix Assisted Pulsed Laser Evaporation to deposit hydroxyapatite nanocrystals at 
different content of alendronate, a bisphosphonate widely employed in the treatments of 
pathological diseases associated to bone loss. The coatings displayed a good degree of 
crystallinity, and the results of in vitro tests indicated that alendronate promotes 
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proliferation and differentiation of osteoblasts even when incorporated into 
hydroxyapatite. 
 
III. Synthesis of drug carriers with a delayed release modulated by a calcium 
phosphate coating. 
 
A core-shell system for modulated drug delivery and release has been developed 
through optimization of the experimental conditions to cover gelatin microspheres with 
a uniform layer of calcium phosphate. The kinetics of the release from uncoated and 
coated microspheres was investigated using aspirin as a model drug. It was shown that 
the presence of the calcium phosphate shell delays the release of aspirin and allows to 
modulate its action. 
 
As result of the research, the papers produced are reported below: 
• A. Bigi, E. Boanini, C. Capuccini, M. Gazzano, Strontium-substituted 
hydroxyapatite nanocrystals.  DOI:10.1016/j.ica.2006.07.074. 
• A. Bigi, C. Capuccini, P. Torricelli, F. Sima, E. Boanini, C. Ristoscu, B. Bracci, 
G. Socol, M. Fini, I. Mihailescu. Strontium-substituted hydroxyapatite coatings 
synthesized by pulsed laser deposition: in-vitro osteoblast and osteoclast 
response. DOI:10.1016/j.actbio.2008.05.005. 
• C. Capuccini, P. Torricelli, E. Boanini, M. Gazzano, R. Giardino, A. Bigi, 
Interaction of Sr-doped hydroxyapatite nanocrystals with osteoclast and 
osteoblast-like cells. DOI: 10.1002/jbm.a.31975. 
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1. Introduction 
 
Biomimetic Materials 
 
Objects with complex shapes and functions have always attracted attention and 
fascination. The morphological diversity and complexity of naturally occurring forms 
and patterns have been a motivation for humans to copy Nature and to adapt ideas from 
Nature to achieve functional, aesthetic, and societal value.  
Scientists and engineers have long envied Nature’s ability to design crystalline 
structure whose properties are often superior to those of similar synthetic materials, 
thanks to the huge timeframe Nature has had to optimize and perfect functional 
materials. 
Through a process called biomineralization, proteins orchestrate the growth processes 
of many natural minerals into designs that confer them exceptional properties. The 
biological control to determine the size, shape, and properties of crystals is a key to 
addressing challenges as diverse as synthesizing nanostructures, characterizing climate 
change, treating disease, and designing new materials for national security applications. 
It follows that to mimic biological materials is a powerful approach for the synthesis 
of advanced materials with complex shape, hierarchical organization and controlled 
size, shape and polymorphism under ambient conditions in aqueous environments. 
Increased understanding of biomineralization mechanisms has greatly enhanced the 
possibilities of biomimetic mineralization approaches. 
Biominerals are promising materials because they combine complex morphology over 
several hierarchy levels with superior materials properties and environmentally friendly 
synthesis and biocompatibility. This makes them very attractive archetypes for materials 
chemists. When studying these materials, the main aim is not to simply emulate a 
particular biological architecture or system, but to abstract the guiding principles and 
ideas and use such knowledge for the preparation of new synthetic materials and 
devices. Based on these ideas a rapidly developing research field has evolved, which 
can be summarized as bio-inspired or biomimetic materials chemistry. The creation of 
superstructures resembling naturally existing biominerals with their unusual shapes and 
complexity, is meanwhile already an important branch in the broad area of biomimetics. 
During the past decade, exploration as well as application of these bio-inspired 
synthesis strategies has resulted in the generation of complex materials with specific 
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size, shape, orientation, composition, and hierarchical organization [2], influenced also 
by organic molecules. 
Organisms have been producing mineralized skeletons for the past 550 million years. 
The mineral phases are often not pure but are made as composites because they contain 
of an organic part too. This is the one which takes part in and controls the 
biomineralization. Morphosynthesis consist of the chemical construction and patterning 
of inorganic materials with unusual and complex architecture [3 - 5]. The complex 
inorganic architectural replication is constructed hierarchically on a length scale from 
the nanometre to the millimetre level. The controlled synthesis of inorganic materials 
with specific morphology is an important aspect in the development of new materials in 
many fields such as catalysis, electronics, nanocomposites, etc. From a materials 
perspective, biomimetic syntheses have permitted the replication of a range of 
organized inorganic forms using, as templates, bacterial colonies [4], insect wings [5], 
spider silk [6] and pollen grains [7], for example. Most of the morphosynthesis routes or 
biomimetic syntheses involve precipitation reactions in self-assembly organic media, 
such as micelles, surfactants and microemulsions [5, 8, 9]. 
During the past 30-40 years there has been a major advance in the development of 
medical materials for biomedical applications, in particular in the innovation of ceramic 
materials for skeletal repair and reconstruction. The materials within this class are often 
referred to as “Bioceramics” and the expansion in their range of medical applications 
has been characterised by a significant increase in the number of patents and 
publications in the field and an ever increasing number of major international 
conferences and themed meetings. Bioceramics are now used in a number of different 
applications throughout the body. According to the type of bioceramics used and their 
interaction with the host tissue, they can be categorised as either “bioinert” or 
“bioactive”, and the bioactive ceramics may be resorbable or non-resorbable. The 
materials used include: polycrystalline materials; glasses, glass ceramics and ceramic-
filled bioactive composites, and all these may be manufactured either in porous or in 
dense form in bulk, as granules or in the form of coatings [10]. 
 
 
 
 
 
 
 
1. Introduction 
 
 
 
9 
Biomaterials for Hard Tissue Repair 
The development of advanced materials for biomedical applications is among the 
most important problems facing modern materials engineering [11]. In recent times, 
problems like osseous tumours, trauma and other debilitating diseases created the need 
to fill defects in the skeleton. Most bone tissue engineering strategies rely on the use of 
temporary scaffolds that can be seeded with cells prior to implantation, or designed to 
induce the formation of bone from the surrounding tissue after implantation. The 
effectiveness of such materials can be highly improved if they can simultaneously act as 
drug delivery systems. Depending on the specificity of the illness, bioactive agents (e.g. 
growth factors or other protein-drugs) can be locally released and potentially accelerate 
the process of bone regeneration. Increasing efforts have been also devoted to the 
development of improved injectable materials aimed at providing an alternative for the 
filling of bone defects with less patient discomfort, as they can be applied through 
minimally invasive surgical procedures. Most injectable materials described in the 
literature consist of pastes, gels or liquid precursors that solidify in situ in response to 
some stimulus. Micro- or nano-particles have also been described, but they must be 
suspended in either autologous blood or other appropriate vehicle prior to injection. A 
variety of injectable materials, both ceramic- and polymer-based, have been developed 
for use in multiple orthopaedic applications. The combination of ceramic particles with 
polymeric matrices has also been extensively investigated in an attempt to mimic bone 
tissue, which may itself be seen as a complex composite material made of organic and 
inorganic components. Different ceramic phases have been used, hydroxyapatite and 
tricalcium phosphate being the most common, as well as several polymeric matrices, 
both of synthetic or natural origin, the latter including collagen, chitosan, gelatin and 
alginate, among others [12]. Calcium phosphate (CaPs) materials are already widely 
used as bone substitutes due to their excellent biological behaviour [13]. Hydroxyapatite 
(HA), for example, forms the main mineral constituent of human hard tissues and 
ceramics constituted by this compound have proved to be biocompatible and bioactive 
materials, which can chemically bond with bone, and have been successfully used 
clinically for repair of bone defects and augmentation of osseous tissues [14]. As a 
matter of fact, the greatest potential for bone substitution is shown by materials based 
on hydroxyapatite, which can develop tight bonding with bone tissue, exhibits 
osteoconductive behaviour, is stable toward bio-resorption, and has no adverse effects 
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on the human organism [15, 16]. Synthetic hydroxyapatite precursors are produced by a 
variety of ceramic processing routes including precipitation, sol-gel and hydrothermal 
processing [17]. Many biological materials are known to have unusual mechanical 
properties, some of which are surprisingly advantageous, especially when taking into 
account the fact that they are formed at ambient temperatures and pressures. This 
observation has inspired many studies of these materials over the last several decades 
aimed at discovering some of their structural ‘secrets’. The mineralized biological 
materials represent an interesting subgroup within this vast world. Clearly the presence 
of the mineral phase and the manner in which the mineral and the organic material are 
organized are among the key factors that contribute to their unique mechanical 
properties. Understanding just how this occurs is, however, not a trivial task, as the 
scale of ordered structures can vary from Angstroms to millimetres. Furthermore, one 
level of structural organization is often nested into another larger-scaled structural type, 
to produce a very complicated overall structure. In order to reveal the design strategies 
of these natural materials we not only have to understand their structural features in 
great detail, but we also need to identify the specific benefits that a particular aspect of 
the structure contributes to the bulk material. With all these difficulties, it is therefore 
not surprising that we still really know very little about the strategies used by organisms 
to form their superior materials. Minerals, macromolecules and water are the major 
components of these materials. More than 60 different minerals are known to be formed 
biologically, but only a small subset of these are common components of endo- and 
exo-skeleton types based on the organization of their mineral constituents. The one type 
is composed of multicrystalline arrays, in which the individual crystals are generally all 
aligned at least in one direction, and often in all three directions. The best known 
examples of such materials are bones, teeth and shells of various types [18]. 
 
 
1.1 Bone Tissue 
 
 
 
Hard tissues are in general ceramic/organic composites with complex microstructure. 
Bone is a complex living tissue which has an elegant structure at a range of different 
hierarchical scales. It is basically a composite comprising an organic and an inorganic 
phases. Water (9 wt. %) is the third major component but its importance for the 
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mechanical functioning of bone has not to be underestimated as demonstrated by the 
results showed by the difference of the mechanical properties of dry and wet bone [19]. 
In fact, the mechanical properties of bone depend largely on the humidity along with 
other parameters such as mode of applied load, direction of the applied load, and kind of 
bone. 
The organic component (ca. 20 wt. %) is based on collagen which regulates 
nucleation and growth of the mineral crystals. Collagen constitutes the main component 
of a three-dimensional matrix into which the mineral forms. The inorganic component 
(ca. 69 wt. %) is constituted by numerous isolated and small calcium phosphate crystals 
of nonstoichiometric carbonated apatite [20] embedded in and held together by collagen 
matrix. 
Strength and the other mechanical properties of bone depend also upon these main 
components. Orientation of the collagen fibers, bone density, and porosity, and the 
molecular structure and arrangement of its constituent apatite crystals within their 
collagen matrix are critical parameters to be considered. 
Collagen is in the form of small microfibers. The collagen arrangement with hole 
zones is necessary for the controlled mineral nucleation and growth, but it may not be 
sufficient [21]. Additionally, other organic materials, such as proteins, polysaccharides, 
and lipids are also present in small quantities and are an integral part of the nucleation 
site being implicated in the mechanism of nucleation. Several studies have clearly 
demonstrated that phosphoproteins, in particular, are either limited or concentrated 
mainly at the site of initial mineralization, in close relationship with the collagen fibrils 
[22]. The phosphoproteins appear to become enzymatically phosphorylated [23], prior 
to mineralization. 
At the molecular level, the triple helices of collagen molecules, secreted by 
osteoblasts, are assembled into microfibrils, with a specific tertiary structure having 67 
nm periodicity and 40 nm gaps, or holes, between the end of the molecules (Figure 1). 
The holes localize a microenvironment containing free mineral ions and bound side 
chain groups, with a molecular periodicity that serves to nucleate the mineral phase 
heterogeneously [24].  
The diameter of the collagen microfibers varies from 100 to 2000 nm. Calcium 
phosphate in the form of crystallized HA and/or amorphous calcium phosphate provides 
stiffness to the bone. 
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The inorganic phase is present in the form of plates or needles, about 40-60 nm long, 
20 nm wide, and 1.5 - 5 nm thick. They grow with a specific crystalline orientation 
parallel to the collagen fibrils, such that the larger dimension of crystals is along the 
long axis of the fiber. It is worth mentioning that the mineral phase present in the bone 
is not a discrete aggregation of the HA crystals. It is rather made of a continuous phase 
which is evidenced by a very good strength of the bone after a complete removal of the 
organic phase. 
The basic building block of bone material is the mineralized collagen fibril (Figure 2) 
that is the combination of collagen’s triple helix with carbonate hydroxyapatite crystals. 
At the next hierarchical level, a conspicuous diversity in structure occurs, with fibril 
arrays organized in a variety of patterns, which can lead to very organized structures 
such as osteons (Figure 3) [25]. 
The result is that bone is usually composed of a relatively dense outer layer (cortical 
bone) surrounding a less dense, porous tissue (cancellous bone) (Figure 4), which is 
filled with a gel-like tissue (bone marrow). This complex tissue is the body’s repository 
for the undifferentiated stem cells that are the precursors to most of the reparative or 
regenerative cells produced after the embryonic organism has formed. 
Cross sections of the compact bone, showing cylindrical osteons (also called 
Harversian system) with blood vessels running along Harversian canals (in the center of 
each osteon) are shown in Figure 5. The metabolic substances can be transported by the 
intercommunicating systems of canaliculi, lacunae, and Volkman’s canals, which are 
connected with the marrow cavity. The various interconnecting systems are filled with 
body fluids and their volume can be as high as 19%. Cancellous bone (also called 
trabecular or spongy bone) is a cellular material consisting of a connected network of 
rods or plates. Low density, open cell, rod-like structures develop in regions of low 
stress while high density, closed cell, plate-like structures occur in regions of higher 
stress [26] 
Adult human bone maintains a dynamic state, which continually undergoes a process 
termed remodelling through the coordinated actions of bone resorption and synthesis, 
through osteoclasts and osteoblasts, respectively. Osteoclasts originate from 
haematopoietic precursor cells, which are possibly present in bone marrow, and 
differentiate into multinucleated cells by the fusion of mononuclear progenitors. 
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Fig. 1 - Representation of bone’s organization. 
 
 
 
 (a) (b)  (c) 
 
Fig. 2 - Bone’s hierarchical levels: isolated carbonate apatite from human bone (a), collagen 
structure (triple helix) (b), and the mineralized collagen fibril (c) (scale bars = 200 nm). 
 
 
 
 
 
Fig. 3 – Single osteon representation, cylindrical motif. 
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The developing multinuclear cells are responsible for the resorption of bone matrix (a 
process involving attachment to the bone surface), establishment of cell polarity, 
migration and subsequent degradation of bone matrix components. Calcium phosphate 
resorption depends on the ability of the osteoclasts to generate an acidic extracellular 
compartment between the cell and the bone surface. An acidic pH value is essential for 
bone mineral dissolution. The primary cellular mechanism responsible for this 
acidification is the active release of protons into the extracellular space. These protons 
allow the solubilization of hydroxyapatite (HA) crystals. The other component of bone, 
the organic bone matrix, which consists of substances such as collagen, is digested by 
acid lysosomal enzymes secreted by osteoclasts. The activity of bone-resorbing cells is 
highly regulated and stimulated by hormones and cytokines. Steroid hormones act on 
various cell types to regulate development, cell proliferation and cell differentiation. 
So, bone is a dynamic tissue that undergoes remodelling even after growth and 
modelling of the skeleton have been completed. 
The remodelling involves the coupled processes of bone resorption and formation. 
The resorption behaviour of osteoclast cells is fundamental to integration of bone 
substitute material [27]. 
In addition, bone has two essential functions: structural material and ion reservoir. 
Both functions depend on a significant extent on the exact size, shape, chemical 
composition and crystal structure of the mineral crystallites and their arrangement 
within the organic matrix [21]. 
 
 
 
 
 
 
 
Fig. 4 – Vertical section of a human bone and its density’s difference: cortical 
(compact) bone surrounds cancellous (spongy) bone. 
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However, although the skeleton plays a vital role in the mammalian body both in 
terms of support and locomotion and also the protection of vital organs, it is susceptible 
to fractures as a result of injury and degenerative diseases which are often associated 
with ageing. Therefore there has always been a need, since the earliest time, for the 
repair of damaged hard tissue. The earliest attempts to replace hard tissue with 
biomaterials aimed to restore basic functions by repairing the defects caused by injury 
and disease with minimal biological response from the physiological environment. The 
materials fulfilling these requirements are now largely classed as “bioinert”. “Bioinert” 
is a term that should be used with care, since it is clear that any material introduced into 
the physiological environment will induce a response. However for the purposes of 
biomedical implants, the term can be defined as a minimal level of response from the 
host tissue in which the implant becomes covered in a thin fibrous layer which is non-
adherent. 
On the contrary, bioactive materials are supposed to stimulate a positive response 
from the host tissue. In this area, calcium phosphates play a fundamental role. 
 
 
 
 
Fig. 5 - Global bone’s organization: compact and cancellous bone. 
(www.web-books.com/eLibrary/Medicine/physiology/Skeletal/skeletal.htm) 
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1.2 CaPs of Biological Interest 
 
Calcium phosphates exhibit a wide range of possible applications, which span from 
their use as catalysts, as starting materials in the preparation of phosphatic fertilizers, as 
columns in chromatographic separation, and as stabilizers for plastics, to the biomedical 
field, where they are applied in the form of nutrient supplements, dentrifice additives, 
and biomaterials. The inorganic phase deposited in mineralized tissues, such as bone 
and dentine, is a poor crystalline carbonated apatite characterized by nanometric 
dimensions of crystals, a low crystallinity and defective stechiometry due to the 
presence of numerous extrinsic ions [28], which, however, could be just the final phase 
of a process involving other calcium phosphates as precursor phases. In particular, 
octacalcium phosphate is thought to be involved in the first stages of mineralization of 
bone and tooth tissues, on the basis of its similarity with hydroxyapatite structure, its 
significantly higher solubility, as well as its reported involvement in the formation of 
several calcified tissues. The interest towards the chemical nature of the possible 
products of -tricalcium phosphate hydrolysis justifies its increasing employment in 
calcium phosphate bioactive bone cements. 
As already discussed, calcium phosphates in general form the mineral component of 
bones and teeth, occur in pathological calcification, and provide bones, teeth and 
tendons their hardness and stability. Furthermore they are widely distributed minerals 
[29, 30]. 
A number of features make calcium phosphates ideal biomaterials including the 
ability to form strong interfacial bonds with bone tissue without fibrous encapsulation; 
facilitate the growth of bone tissue so as to achieve early mechanical bone fixation; and 
act as scaffolds on which bone-forming cells (osteoblasts) can attach, grow, divide and 
form new bone [31]. 
Accordingly, apatites and other calcium phosphates are increasingly used as 
biocompatible and bioactive materials in orthopaedic and dental applications. 
During the last forty years, important progress has been made in the understanding of 
the structure and chemistry of the apatites and related calcium phosphates. Although the 
basic apatite structure had been determined in 1930, at the beginning of this period 
substantial aspects of the structures of the other calcium orthophosphates were unclear. 
The existence of one of them, octacalcium phosphate, had not been universally accepted 
and little was known about the amorphous calcium phosphate. As regards the apatites, 
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there were still disputes about the location of carbonate in biological and many mineral 
apatites. Another matter of investigation was that apatites could be precipitates from 
solutions with Ca/P molar ratios from the stoichiometric value of 1.67 to about 1.5, 
without any apparent changes in the X-ray diffraction powder pattern. 
The calcium orthophosphates are salts of the tribasic phosphoric acid, H3PO4, and thus 
can form compounds that contain H2PO4-, HPO42-, PO43- ions (their list is reported in 
Table 1). Those with H2PO4- ions only form under rather acidic conditions, therefore are 
not normally found in biological systems. However, both HPO42- and PO43- ions occur 
in the mineral of bones and teeth and in various pathological calcifications. Some 
calcium phosphates are hydrated, and those that belong to the basic apatitic calcium 
phosphate family contain OH- ions. 
The calcium phosphates are all white solids, unless doped with a coloured ion. Most 
are sparingly soluble in water and some are very insoluble, but all dissolve in acids. 
The crystallization of complex and lightly soluble apatitic structures evolves through 
the formation of intermediate products which are thermodynamically metastable but 
cinetically favourite. 
In vitro, amorphous calcium phosphate converts into octacalcium phosphate (OCP) 
which on its turn converts into carbonate hydroxyapatite; at lower pH values the 
intermediate phase seems to be dicalcium phosphate dehydrate (DCPD). 
Calcium phosphates with their relative abbreviation, formula and Ca/P ratio can be 
found in Table 1. 
 
1.2.1 Hydroxyapatite 
 
Hydroxyapatite [HA, chemical formula Ca10(PO4)6(OH)2] is widely studied as an 
artificial bone and teeth replacement material in dental and orthopaedic implants, as 
coating of hard tissue implants, bone fillers, and for drug delivery, due to its chemical 
and crystallographic resemblance to bone and tooth minerals. HA is known to have an 
appropriate biological activity when implanted in living organisms and this property has 
attracted growing interest in the last decades. The goal of the biomaterials synthesis and 
processing nowadays is to mimic the way materials have been created in nature. 
Organisms in nature create perfect fine mineralized structures with diverse biological 
functions and very often from simple salt solutions through interactions between 
inorganic and organic substances. Stimulated by fascinating natural examples, such as 
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bones, teeth, cartilage, shells and corals, attempts are being made to develop synthetic, 
biomimetic nanocomposites by simulating the basic principles of biomineralization 
[32]. 
HA is well suited for its use as a bioactive coating for medical and dental implants. 
HA coatings have been proven to promote rapid osseointegration which results in 
earlier and superior implant stabilization. The degree of integration between bone and 
implant material results from the material’s ability to mimic the natural properties of 
bone such as chemical composition, surface and mechanical properties, as well as grain 
size structure. 
 
 
 
 Table 1 - Calcium orthophosphates. 
 
COMPOUND  ABBREVIATION FORMULA Ca/P 
Dihydrogen calcium 
phosphate monohydrate 
MCPM Ca(H2PO4)2⋅H2O 0.5 
Dihydrogen anhydrous 
calcium phosphate 
MCPA Ca(H2PO4)2 0.5 
Dihidrate calcium 
hidrogen phosphate 
DCPD CaHPO4⋅2H2O 1.0 
Anhydrous calcium 
hydrogen phosphate 
DCP CaHPO4 1.0 
Octacalcium phosphate OCP Ca8H2(PO4)6⋅5H2O 1.33 
α-Tricalcium phosphate α-TCP α-Ca3(PO4)2 1.5 
β-Tricalcium phosphate β-TCP β-Ca3(PO4)2 1.5 
Hydroxyapatite HA Ca10(PO4)6OH2 1.67 
Tetracalciumphosphate TTCP Ca4(PO4)2° 2.0 
Amorphous calcium 
phosphate 
ACP   
 
 
The plate-like HA crystals that make up the inorganic phase of bone are 20 to 80 nm 
long and 2 to 5 nm thick and can be categorized as a nanophase material because they 
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have grain sizes less than 100 nm in at least one direction. Studies have shown that 
ceramic biomaterials, including HA, with a nanophase crystalline structure more readily 
promote cellular activity related to bone growth than ceramic biomaterials with 
conventional crystal structures. 
The crystallinity of an hydroxyapatite coating, which is typically dependent on the 
processing method and whether the coating is subject to a heat treatment, determines the 
dissolution rate of the coating in vivo. Poor crystalline HA is readily dissolved in the 
body and promotes cell growth while crystalline HA dissolves slower or not at all, thus 
allowing more time for bone formation and bone ingrowth [33]. 
Apatites, in general, have the formula Ca5(PO4)3X, where X can be an OH- ion 
(hydroxyapatite), a F- ion (fluoroapatite) or a Cl- ion (chlorapatite), for example. The 
apatite structure is very tolerant for ionic substitutions, so Ca2+ ions can be partly or 
completely replaced by Ba2+, Sr2+ or Pb2+ ions and PO43- by AsO43- ions. Thus, there are 
lead minerals with apatitic structure such as Pb5(PO4)3Cl (pyromorphite), Pb5(VO4)3Cl 
(vanadite) and Pb5(AsO4)3Cl (mimetite). Coupled substitutions frequently occur in 
apatites, where one ion is replaced by another of the same sign, but different charge, and 
neutrality is maintained by substitutions of ions with dissimilar charge or vacancies 
elsewhere. 
The carbonate apatites have been the subject of many studies. These include the 
minerals francolite, dahllite and the rock-phosphates, and the biological apatites. 
Nonstoichiometry, with vacant lattice sites, occurs in biological apatites and frequently 
in synthetic ones, which considerably complicates their crystal chemistry. 
Pure HA crystallizes in the monoclinic space group P21/b. However, the presence of 
impurities stabilizes the hexagonal structure at room temperature. The basic apatite 
hexagonal structure, space group P63/m, exhibits approximate lattice parameters a = 
9.43 Å and c = 6.88 Å with two formula units per cell. This is the reason why a double 
formula is often used [Ca10(PO4)6X2]. The values often depend on the mode of 
preparation because of the frequent nonstoichiometry. 
The P63/m space group has three kinds of vertical symmetry elements (Figure 6): (1) 
six-fold screw axes passing through the corners of the unit cells marked by dashed lines 
in the figure. These symmetry elements are equivalent to a three-fold rotation axis with 
a superimposed two-fold screw axes; (2) three-fold rotation axes passing through 2/3, 1/3, 
0 and 1/3, 2/3, 0; and (3) two fold screw axes passing through the mid points of the cell 
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edges and its centre. There are also mirror planes perpendicular to the c-axis at z = ¼ 
and ¾, and numerous centres of symmetry. 
There are columns of Ca2+ ions spaced by one-half of the c-axis parameter along the 
three-fold axes at 2/3, 1/3, 0 and 1/3, 2/3, 0 which account for two-fifths of the Ca2+ ions in 
the structure. These ions are given the designation Ca(1) or Ca(I) or Ca1. 
The site they occupy is often called columnar site. Each of these Ca2+ ions is 
connected to its neighbouring Ca2+ ions above and below by three shared oxygen atoms 
that lie in the mirror plane (Figure 6). On one side, there are three O(1) atoms at 
2.397(1) Å, and on the other side three O(2) atoms at 2.453(1) Å. Each Ca(1) ion is also 
coordinated by three further oxygen atoms, O(3), at a greater distance (2.801 (1) Å) at 
approximately the same z parameter as the Ca2+ ion. Thus the columnar Ca2+ ions are 
nine-fold coordinated by oxygen atoms. These columns of Ca2+ ions and their 
coordinated oxygen atoms are linked together by PO4 tetrahedra in which three oxygen 
atoms come from one column, and the fourth from the adjacent column. 
The result is a three-dimensional network of PO4 tetrahedra with enmershed columnar 
Ca2+ ions and with channels passing through it.  
 
 
 
 
    
 
 
 
 
 
 
 
 
     Inversion hexad axis 
     63 screw axis 
     21 screw axis 
     Centre of symmetry 
 
Fig. 6 – Vertical symmetry elements of the space group P63/m. The dashed lines indicate the 
apatite unit cells with the c – axis out of the diagram. There are also horizontal mirror planes at z 
= 
¼
 and ¾ and numerous centers of symmetry. 
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The axes of these channels coincide with the six-fold screw axes and the corners of 
the unit cells, and one forms the c-axis. 
The remaining ions, OH- and their adjacent Ca(2) ions that are required to complete 
the structure are located in the channels. These channels have sic caves per c-axis repeat 
of the unit cell, centred on the mirror planes at z =1/4 and 3/4, into which Ca(2) ions can 
fit. These ions form two triangles of Ca2+ ions rotated by 60° from each other about the 
c-axis (Figure 7) at whose centres the OH- are located. Thus the OH- ions are three-fold 
coordinated by Ca2+ ions, with all four ions lying on a mirror plane. The Ca(2) ions 
occupy the so-called triangular site. 
 
 
 
Fig. 7 - Parallel canals to c-axis constituted of Ca 2+ (2) ions that occupy equilateral 
trialgles’ vertexes (in blue) and inside this triangles OH- ions take place. 
 
 
 
1.2.2 OctaCalcium Phosphate 
 
OCP has been supposed to be a precursor of biological apatite. Generally, OCP is 
observed in pathological biomineralization such as dental calculus [34]. In addition to 
this roles in the formation kinetics and composition of apatites, OCP has been found as 
a constituent in dental calculus and other pathological calcifications [35]. Furthermore, 
it has been reported in X-ray powder diffraction of bone from the distal metaphysic of 
rabbit [36] and it was found in a crystal of calcifying dentine together with apatite [37]. 
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By X–ray diffraction it is possible to follow new bone formation. The implanted OCP 
has been shown to convert to the apatitic phase, through hydrolysis of the OCP to 
apatitic crystal and/or re-mineralization of the OCP after dissolution [38]. 
So, understanding the growth of OCP and its hydrolysis to HA is important in order to 
understand the processes of mineralization in human tissues. The close structural 
relationship between OCP and HA can explain the incorporation via hydrolysis of 
impurities (especially Mg2+ and CO32-) and so the frequent non-stoichiometry of 
precipitated apatites. 
Octacalcium phosphate [OCP, Ca8H2(PO4)6  5H2O] is also referred to as octacalcium 
bis(hydrogenphosphate) tetrakis(phosphate) pentahydrate or tetracalcium hydrogen 
triphosphate trihydrate. 
A calcium phosphate with the composition of OCP was first described in 1836 [39], 
but its existence was not universally accepted until the middle of 20th century, and its 
importance unrecognized until the early 1960s. 
OCP crystallizes in a triclinic structure [40, 41], space group P 1  and unit cell a = 
19.692(4) Å, b = 9.523(2) Å, c = 6.835(2) Å,  = 90.15(2)°,  = 92.54(2)° and  = 
108.65(1)°. The asymmetric unit is  Ca8H2(PO4)6  5H2O with two units per unit cell. 
OCP crystals are {100} blades of triclinic pinacoidal symmetry, elongated along the 
c-axis. It is a layered structure parallel to (100) where apatitic layers about 1.1 nm thick 
alternate with a hydrated layers about 0.8 nm thick (Figure 8). 
 
 
 
       Hydrated layer 
        Apatitic layer 
 
 
Fig. 8 - Layered structure of Octacalcium phosphate. 
 
 
The presence of the apatitic layer explains the similarity of lattice parameters with 
those of HA (a = 9.4176 Å and c = 6.8814 Å), since that layer consist of phosphate ions 
interdispersed with Ca2+ ions resembling the ions positions in the structure of apatite 
The hydrated layer consists of more widely spaced phosphate and calcium ions with a 
slightly variable number of water molecules between them. Six of the Ca2+ ions and two 
(100) 
 
 
(010) 
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of the phosphate ion are in the apatitic layer, the other two Ca2+ ions and one phosphate 
ion are in the hydrated layer and the remaining three phosphate ions lie at the junction 
of the apatitic and hydrated layers. The phosphate ion in the hydrated layer and one at 
the junction between the layers are protonated (Figure 9). 
 
 
1.2.3  -TriCalcium Phosphate 
 
Increasing attention has been paid in recent years to alpha-tricalcium phosphate [-
TCP, -Ca3(PO4)2], which is used as the main constituent of calcium phosphate 
bioactive bone cements and biphasic calcium phosphate ceramics. Its hydrolysis and 
conversion into apatite phase may play an important role in new bone formation in vivo. 
These bone cements can be easily moulded during operation and simply implanted or 
injected into the bone defects, and will turn into apatite after setting and hardening. 
Bonding with bone will finally be realized through the converted apatite phase. This 
distinguishing feature of the bone cements can be attributed to the hydrolysis of -TCP 
to a large extent [14]. 
The adjective anhydrous is used to distinguish it from hydrated apatitic precipitates 
that have similar Ca/P molar ratio of 1.5. It was first reported in 1932 [42]. 
-TCP is highly reactive in aqueous systems and can be easily hydrolyzed to a 
mixture of other calcium phosphates. -TCP crystallizes in a monoclinic structure, 
space group P21/a and unit cell a = 12.887(2) Å, b = 27.280(4) Å, c = 15.219(2) Å and  
= 126.20(1)°, with 24 formula units per unit cell [43]. There is an approximate subcell 
with a b-axis parameter of b/3 (9.09 Å) that contains 8 formula units, which corresponds 
to the unit cell reported earlier [44]. 
The structure of -TCP is constituted of columns of Ca2+ and PO43- ions which run 
parallel to the c-axis. 
The section of the structure of -TCP that corresponds to a unit cell of apatite is 
marked with dotted lines in Figure 10. 
The correspondence can also be seen from a consideration of the dimensions of the 
unit cell of -TCP with those of apatite: the -TCP approximate subcell b-axis 
parameter of 9.09 Å corresponds to the apatite a-axis parameter, whilst half the c-axis 
parameter of -TCP (7.6 Å) corresponds to the c-axis parameter of apatite. The apatite 
structure can so be derived from -TCP by replacing the cation-cation columns at the 
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corners of the apatite cell by anion columns (OH- in hydroxyapatite, F- in 
fluoroapatite…). 
 
 
 
Fig. 9 – Structure of octacalcium phosphate projected onto the (001) plane, showing the 
relationship with the structure of apatite. The unit cell of OCP (lower left one) and of HA (upper 
right one) have been drawn. The c – axis is out of the plane of the diagram for OCP and into the 
plane for HA. 
 
 
 
 
 
 
 
      
    P below Ca 
    P above Ca 
    Ca 
 
Fig. 10 - Projection of -TCP structure onto the (001) plane. The dotted lines 
outline the apatite unit cell 
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The remaining cation columns in -TCP become the columnar Ca(1) ions in apatite, 
whilst the PO43- and Ca2+ ions that form the cation-anion columns in -TCP have very 
approximately the same position as the PO43- and Ca(2) ions in apatite. 
 
 
1.2.4  DiCalcium Phosphate Dihydrate 
 
Dicalcium phosphate dihydrate [DCPD, CaHPO4  2H2O] is also referred to as 
calcium monohydrogen phosphate dehydrate or dibasic calcium phosphate dihydrate or 
calcium hydrogen orthophosphate 2-hydrate. 
Its mineral (brushite) was discovered in 1865 and named by the mineralogist G.J. 
Brush [45]. Brushite occurs as a component of rock-phosphate deposits and in dental 
calculus [35] and other pathological calcifications [46]. DCPD can occur as an 
intermediate in the apatitic mineralization and dissolution processes [47, 48]. It can be 
easily crystallized from aqueous solutions. At temperatures above 80°C, it transforms 
into the anhydrous form DCPA. 
The first structure proposed for DCPD consisted in a centrosymmetric space group 
[49], but this was inconsistent with the subsequent finding of piezoelectricity 
characteristics, which means a non-centrosymmetric structure. The absence of a centre 
of symmetry has been confirmed later [50] by refining the first measurements. DCPD 
crystallizes in a monoclinic structure, space group Ia and unit cell a = 5.812(2) Å, b = 
15.180(3) Å, c = 6.239(2) Å, and  = 116.25(2)°. 
The asymmetric unit is CaHPO4  2H2O with four formula units per unit cell. 
The structure contains columns of alternating Ca2+ and HPO42- ions, which run 
parallel to the short diagonal of the (010) face of the unit cell.   
A striking feature of this structure is that these columns are joint together to form 
corrugates sheets (Figure 11). The sheets, that result to have a composition of CaHPO4, 
are normal to the b-axis and are linked together by water molecules. 
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Fig. 11 – Structure of one of the corrugated sheets that characterize DCPD. The 
b – axis is into the plane. The arrows indicate the directions of four CaHPO4 
chains (the bonds in the 3rd one are dotted for emphasis). 
 
 
 
1.3 CaPs for Hard Tissue Repair 
 
 
Reconstruction of large bone defects that are resulting from trauma, neoplasms, or 
infection is a substantial biomedical burden in oral and maxillofacial surgery. 
Autogeneous bone grafting is commonly used to repair the critical sized bone defect, 
whereas it has disadvantages of limited availability and morbidity that is associated with 
harvesting bone from a second operative site. In the case of allograft, it has the potential 
for adverse immunological reaction and/or disease transmission. Therefore, it has been 
expected to develop synthetic biomaterials that overcame the disadvantages of 
autogeneous and allogeneous bone grafting. 
Today, it has been accepted that main components for bone regeneration are stem 
cells or osteoprogenitors, an appropriate biological scaffold, and cytokines. Newly 
developed synthetic biomaterial should be a substitute for extracellular matrix, which 
could be resorbed and replaced by the host tissue, activates osteoprogenitors, and 
sustain and deliver cytokines appropriately. 
Calcium phosphates, in the form of powders, dense and porous ceramics, composites 
and cements, attract great interest as biomaterials because of their good biocompatibility 
Ca 
P 
O 
c 
a 
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and bioactivity, which make these compounds particularly suitable for hard tissue 
replacement.  
There is, in fact, a necessity for replacing bone substance which has been lost due to 
traumatic or non-traumatic events. The lost bone can be replaced by endogenous or 
exogenous bone tissues, which is connected with several problems. The use of 
endogenous bone substance involves additional surgery: moreover, the endogenous 
bone is available only in limited quantities. The major disadvantage of exogenous bone 
implants is that they may be rejected by the human body, diseases may be transmitted 
together with the implant, also the clinical performance of exogenous bone is 
considerably inferior to fresh endogenous graft material. For these reasons, there is a 
growing need for fabrication of artificial hard tissue replacement implants. The 
biomaterials industry worldwide has an annual turnover of 2.3 billion of dollars in the 
field of hard tissue repair and replacement. There is currently a projected growth rate of 
7-12% per annum for biomaterials in clinical applications. Although the biomaterials 
sector is expanding, it is expected that the volume of materials required will never 
exceed tens of tons, as compared with thousands of tons for other developing 
engineering markets. Reconstructive orthopaedic surgery methods involving autogenous 
and allogenous bone grafting are currently used to treat large bone defects. Due to their 
serious limitations, severe clinical problems have arisen and new approaches for bone 
tissue repair are essential. The main advantage of using bone allografts or autografts is 
their osteoconduction. However, allografts can lead to an immune response, which 
requires long-term medication. Another major problem is the risk of transferring 
diseases (e.g. AIDS or hepatitis). Currently, autografts are better alternatives for 
repairing bone defects caused by tumours and serious trauma. However, the use of these 
substitutes is also restrictive. In the autograft procedure not only is the operation time 
increased, but morbidity at the donor site is more frequent, which poses a high risk to 
the patient’s health. Therefore, synthetic calcium phosphate ceramics are becoming 
more widely used as bone substitutes in orthopaedic and oral surgery. Synthetic bone 
substitutes can solve certain problems associated with bone transplantation. An ideal 
synthetic material should provide a framework for continuous bone resorption and bone 
deposition [51]. 
The surface properties of calcium phosphate constituted biomaterials, such as 
hydroxyapatite (HA), fundamentally govern their overall interface function, which 
includes biological processes such as adsorption of biomolecules, apatite crystal 
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dissolution, nucleation and growth, thereby modulating the biomineralization process. 
The prototype for minerals in bones and teeth is usually considered to be basic calcium 
phosphate HA, with impurities such as carbonate and acid phosphate. Biological 
apatites display better crystallinity and a higher Ca/P molar ratio with mineral 
development. Several precursor phases have been proposed to explain the non-
stoichiometric composition of biominerals. These precursors are dicalcium phosphate 
dihydrate (DCPD), octacalcium phosphate (OCP) and amorphous calcium phosphate 
(ACP). OCP was first proposed by Brown et al. [41] to participate as the initial mineral 
crystals in bones and teeth that subsequently hydrolyze into HA. Debates continue 
relating to the chemical nature of the first mineral crystals formed in biomineralization. 
Based on in vitro crystal growth studies that ACP and DCPD can be hydrolyzed to HA 
via OCP, OCP has been suggested as the direct precursor to HA. Several lines of 
evidence support the involvement of OCP as the initial crystal formation in dentin, 
enamel and bone minerals. Previous studies showed that implantation of OCP enhanced 
bone formation accompanied by in situ conversion of the OCP into an apatite structure 
[52]. 
 
 
 1.3.1 Modified CaPs 
 
 
Apatites are a family of inorganic crystalline compounds, of general formula 
M10(XO4)6Y2. M is usually a bivalent cation, such as Ca2+, Sr2+, Ba2+, Cd2+, Pb2+, but 
monovalent and trivalent cations, such as Na+, K+ and Al3+, can be hosted as well; XO4 
is usually PO43-; VO43- or AsO43, but the possible substitutions also include SiO44-; 
CO32- and SO42-; Y is a monovalent anion, OH-, F-, Cl-, Br-. Apatites are widely spread 
in nature; in particular, the inorganic phase of the hard tissues of vertebrates is 
assimilated to the synthetic hydroxyapatite Ca10(PO4)6(OH)2, CaHA. The similarity with 
biological apatites accounts for the high biocompatibility of synthetic CaHA, which 
displays many other properties and exhibits a wide range of potential practical 
applications as a bioceramic, catalyst, liquid-chromatographic column, lighting 
material, chemical sensor. The size and morphology of the individual particles, as well 
as the kind and extent of isomorphous substitutions greatly affect many of the physico-
chemical properties of the apatites. 
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The great variety of possible cationic and anionic substitutions is justified by the high 
stability and flexibility of the apatite structure 
 
1.3.1.1 Strontium 
 
Among the bivalent cations that can replace calcium in CaHA, strontium has attracted 
a remarkable interest for its possible biological role. 
Strontium is one of the alkaline earth metals. It never occurs free in nature, because 
metallic Sr oxidises easily forming strontium oxide, which has a yellowish colour. 
Strontium is well known from the minerals celestite (SrSO4) and strontianite (SrCO3). 
Natural Sr is a mixture of four stable isotopes: 84Sr (0.56%), 86Sr (9.86%), 87Sr (7.02%), 
and 88Sr (82.56%). The elements of group 2 of the periodic system, to which Sr belongs 
along with Ca and Mg, form divalent cations in biological fluids, and have varying 
degrees of protein binding in biological fluids like serum or plasma. 
Radioactive Sr isotopes are dealt with only when they are used for physiological or 
diagnostic purposes. Some of the Sr radioisotopes can be used in medicine. They have 
been used as excellent tools for kinetic studies, substituting for Ca in kinetic 
investigations because the two metals behave very much alike in the human body, both 
having strong bone-seeking properties. 
However, biological differences between the two elements exist, explicable in part by 
the larger size of the Sr molecule. 
Toxic symptoms due to overdosing of Sr have not been reported in man. However, 
intravenous administration of high doses of Sr induces hypocalcaemia due to increased 
renal excretion of Ca. 
The only stable Sr-containing chemical that is considered to be harmful to humans in 
small amounts is strontium chromate, the toxicity being caused by the chromium which 
is a genotoxic carcinogen. 
The amount of Sr in the skeleton is only 0.035 of its Ca content. Radiostrontium is 
cleared from the blood almost immediately after injection [53].  
It is present in the mineral phase of the bone, especially at the regions of high 
metabolic turn-over, and its beneficial effect in the treatment of osteoporosis is well 
known. In vitro, strontium increases the number of osteoblasts and decreases the 
number and the activity of osteoclasts, whereas strontium administration reduces bone 
resorption and stimulates bone formation. Strontium can replace calcium in the HA 
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structure in the whole range of composition. The solid solutions, which have been 
obtained by hydrothermal methods or by treatment at high temperatures, display a linear 
variation in the lattice parameters with composition, whereas different data are reported 
on the preferential substitution site of Sr for Ca in CaHA. A better understanding of the 
interaction of Sr with hydroxyapatite structure could provide useful information also for 
clarifying the biological role of Sr in the process of biomineralization of bone and 
related pathologies [54] even though the role of strontium in human pathology had 
attracted less attention than the other two important divalent metals, calcium and 
magnesium. However, there has been an increasing awareness of the biological role of 
strontium since the development of the drug strontium ranelate, which has recently been 
shown to reduce incidence of fractures in osteoporotic patients. In fact, strontium is a 
trace element that is found in calcareous rocks and ocean water; it is also a natural 
component of food and beverages but there is growing evidence that strontium has a 
beneficial effect on bone because of its ability to enhance bone volume and prevent 
bone loss. In line with its chemical analogy to calcium, strontium is a one seeking 
element and 98% of the total body Sr content can be found in the skeleton. Sr has 
become increasingly popular in the prevention and treatment of osteoporosis as a 
ranelate compound. Sr has been associated with improving postmenopausal 
osteoporosis by reducing bone resorption and increasing bone formation with an 
eventual effect of decreasing the risk of fractures. The currently available data indicate 
that strontium administration at low dose reduces bone resorption and increases bone 
formation, resulting in increased bone mass in normal orovariectomized animals. In 
vitro studies revealed that strontium ranelate (SR) has an anabolic and antiresorptive 
activity which leads to an increase in both the collagen and non-collagen protein 
synthesis, an enhancement in pre-osteoblast differentiation, an inhibition in osteoclast 
differentiation, and a reduction in osteoclast function [55, 56]. 
 
 
1.3.1.2 Magnesium 
 
Another interesting ion from a biological point of view is magnesium. Magnesium 
deficiency in humans was first described in the medical literature in 1934. The adult 
human daily nutritional requirement, which is affected by various factors including 
gender, weight and size, is 300-400 mg/day. Inadequate magnesium intake frequently 
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causes muscle spasms, and has been associated with cardiovascular disease, diabetes, 
high blood pressure, anxiety disorders, migraines, osteoporosis and cerebral infarction. 
Acute deficiency (see hypomagnesemia) is rare, and is more common as a drug side 
effect (such as chronic alcohol or diuretic use) than from low food intake per se, but it 
can also occur within people fed intravenously for extended periods of time. The 
incidence of chronic deficiency resulting in less than optimal health is debated. A 
balance of magnesium is vital to the well being of all organisms. Magnesium is a 
relatively abundant ion in the lithosphere and is highly bioavailable in the hydrosphere. 
This ready availability, in combination with a useful and very unusual chemistry, may 
have led to its usefulness in evolution as an ion for signalling enzyme activation and 
catalysis. However, the unusual nature of ionic magnesium has also led to a major 
challenge in the use of the ion in biological systems. Biological membranes are 
impermeable to Mg2+ (and other ions) so transport proteins must facilitate the flow of 
Mg2+, both into and out of cells and intracellular compartments [57]. Magnesium ions 
appreciably retard the rate of OCP growth, probably by adsorption at active growth site 
and this property could be useful to obtain better and better biomaterials [58]. 
 
 
1.3.1.3 Manganese 
 
The insufficiency of manganese in human body is a probable cause of osteoporosis. 
Its induced lack in animals retards bone growth and provokes skeletal deformities. In 
fact, manganese is an essential trace nutrient in all forms of life. The classes of enzymes 
that have manganese cofactors are very broad and include oxidoreductases, transferases, 
hydrolases, lyases, isomerases, ligases, lectins, and integrins. The reverse transcriptases 
of many retroviruses (though not lentiviruses such as HIV) contain manganese. The best 
known manganese-containing polypeptides may be arginase, the diphtheria toxin, and 
Mn-containing superoxide dismutase (Mn-SOD). The human body contains about 10 
mg of manganese, which is stored mainly in the liver and kidneys. 70% of Manganese 
present in the human organism is contained in the skeletal structure. It is essential for 
bone and teeth enamel growth. It has also a very important role in the glycolysis 
process. Although the biological effects of manganese deficiency are well established in 
several animal species, no role in human nutrition has yet been described. Animals 
rendered manganese deficient show retardation of growth, skeletal and muscular 
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abnormalities, and neurological signs. The human requirement for manganese is very 
low and even during prolonged therapies no clear evidence of deficiency has emerged. 
However, because of the potential importance of manganese, additives containing the 
element have been included in therapy regimens. Earlier, some trace element additives 
contained too much manganese leading to brain abnormalities shown on magnetic 
resonance imaging and, in a few cases, Parkinson's Disease-like symptoms. Current 
additives contain less manganese but children with liver problems can still accumulate 
this element. For whole blood where the normal concentrations are about ten-fold 
higher than in serum, the manganese from contamination is proportionally less 
significant and so no special precautions are necessary in sampling. Manganese toxicity 
is a known problem in metal refining and manganese ore production. Respiratory illness 
and eventually neurological effects are seen after years of heavy exposure. No 
guidelines for biological monitoring are available. It was shown that the presence of 
small amounts of Mn2+ in the apatitic structure leads to better osteoconductive 
properties of metallic prosthesis coatings [59]. This ion is able to activate a receptors 
family, the integrins, that control the interactions between the cellular surface and the 
extracellular matrix [60, 61]. 
 
 
 1.3.1.4 Bisphosphonates 
 
Bisphosphonates (BPs) were introduced in the 1970s for the management of disorders 
of bone metabolism, associated to bone loss. In particular, they are widely used for the 
treatment of tumor-induced hypercalcemia, Paget’s disease and osteoporosis [61 - 63]. 
These chemical compounds are synthetic analogues of pyrophosphate in which the P-
O-P group is replaced by the P-C-P bridge. Individual BPs are characterized by the two 
covalently bonded side-chains attached to the central carbon atom, termed R1 and R2, 
which determine the efficiency of the compound. Binding to bone is enhanced when R1 
is a hydroxyl group, whereas the R2 side group has some effect on binding but 
predominantly it determines the antiresorptive potency of the bisphosphonates [61, 64 - 
66] . 
The presence of nitrogen groups within the R2 side group is associated with the ability 
of an individual BP to inhibit farnesyl pyrophosphate (FPP) synthase, a major enzyme 
in the mevalonate pathway. This results in the disruption of many of the activities of the 
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osteoclasts, including migration, attachment, and resorption. Ultimately, cell death can 
occur via apoptosis [67]. 
Prolonged use of bisphosphonates, especially through intravenous preparations, has 
been recently associated to over suppression of bone metabolism and to possible 
osteonecrosis of the jaws [65]. Local administration might be helpful against the 
potential negative effects of their prolonged use. However, the great affinity of BPs for 
calcium hinders the direct synthesis of hybrid calcium phosphate crystals, as shown by 
the sudden precipitation of amorphous calcium alendronate that occurs when 
alendronate is introduced in the synthesis medium of hydroxyapatite [68]. 
Composite HA nanocrystals at different alendronate content, up to 7.1 %wt, were 
synthesized in aqueous solution thanks to a strategy based on a slight modification of a 
classical method of synthesis of HA [69]. The results of the structural refinements 
carried out on the composite nanocrystals were interpreted as suggesting that 
alendronate interacts with calcium ions through a bidentate chelation of deprotonated 
oxygen atoms of the bisphosphonate anion without greatly affecting the crystal structure 
of HA [70]. In-vitro tests demonstrated that alendronate is able to promote osteoblast 
activation and extra-cellular matrix mineralization processes, and to inhibit osteoclast 
proliferation even if incorporated in the composite nanocrystals [71].  
 
1.3.2 Coatings 
 
Several non-metallic materials have been proposed as candidates for artificial bones 
and/or teeth, but none has found wide applications.  
Clinical success of the implant requires the simultaneous achievement of a stable 
interface with connective tissue and a match of a mechanical behaviour of the implant 
with the tissue to be replaced. 
Moreover, the material biocompatibility is very important in medical applications and 
therefore the interactions of the cells with the materials have been intensively 
investigated. Cells are highly sensitive to topography, roughness, chemistry, surface 
charge, and hardness. Cell–material interactions in vitro may be approximated by the 
process of cell adhesion and spreading, which is a convenient way to determine the 
biocompatibility of a material [32]. 
Pure etched titanium is already widely used in the orthopaedic field (Figure 12) on the 
basis of its innocuousness, resistance to corrosion, very low allergic problems and 
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satisfying biocompatibility. Moreover, it provides and grants stable chemistry 
performances. 
However, metallic implants, such as those necessary in total hip-joint replacements 
and artificial tooth sockets, meet mechanical stability requirements, but do not form 
mechanically stable bonds to bone tissue. The high incidence of bone implant failures is 
mainly blamed on incomplete osteointegration and stress shielding due to significant 
differences in mechanical properties between the implant and surrounding bone [70, 
71]. 
Improved implant fixation to hard tissues can be achieved by coating the metallic 
surface with a thin film of calcium phosphates The deposition of calcium phosphates 
films on medical implants enable to combine the high mechanical strength of metallic 
implant with excellent bioactivity of the calcium phosphates surface layers.  
Therefore it is important to develop calcium phosphate coatings characterised by the 
proper chemical composition and physical characteristics [72 - 74]. 
 
 
 
   
 
 
 
 
 
Fig. 12 - Examples of titanium bone prostheses. 
(www.colognesurgicale.com) 
 
 
1.3.2.1 Pulsed Laser Deposition 
 
Coatings can be deposited by several physical and chemical methods, including 
plasma spray, pulsed laser deposition, sputtering, electrodeposition, anodic deposition 
and anodic spark deposition, sol-gel dipping and biomimetic deposition [75 - 90]. 
Among these numerous techniques, pulsed laser deposition is commonly used to 
produce calcium phosphate coatings. This method is characterized by high deposition 
rate as well as possibility of precise controlling of thickness and composition of a 
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growing layer. The physical and chemical properties of deposited layers can be 
controlled by changing conditions of PLD process. The basic parameters of the above 
method are pressure of ambient gas, laser fluence, substrate temperature, wavelength 
and repetition of laser pulses [81]. 
PLD allow to produce coated metallic prosthetic devices which bond strongly to the 
bone material that surrounds the bone intended to be replaced by the device by 
encouraging bone ingrowth into the coating, while retaining immunity from 
delamination and separation of the coating from the metal. PLD, so, gives ideal coatings 
with an intermediate metal–ceramic region with a compositionally gradient interface 
which reduce interfacial problems and enhance in vivo lifetime [77 - 87]. 
PLD has proved to be a successful technique for growing thin calcium phosphate 
structures on metallic substrates. PLD uses short, mostly UV, pulsed laser beams to 
expel the species and then focus them onto a target that rotates under a controlled 
atmosphere in a reaction chamber. The stoichiometry and crystallinity of the deposited 
material that forms the coating can be selected by a proper choice of the ablation and 
deposition parameters [88 – 91]. 
In PLD (Figure 13), a pulsed laser beam strikes the surface of the source material, 
also called the target, and the energy from the laser evaporates the target’s surface. 
In most materials, the ultraviolet radiation is absorbed by only the outermost layers of 
the target to a depth of about 1 Å. The extremely short laser pulses, each lasting less 
than 50 ns, cause the temperature of the surface to rise rapidly to thousands of degrees 
Celsius, but the bottom of the target remains virtually unheated, close to room 
temperature. Such non-equilibrium heating produces a flash of evaporants that deposit 
on the substrate, producing a film with composition identical to that of the target 
surface. Several aspects make PLD a great technique. It produces a highly forward-
directed and confined plume of materials, which can be deposited with less 
contamination than the unconfined plasma in a sputter process. In addition, PLD is 
incredibly precise. 
PLD does not require any monitoring, because the composition of the film replicates 
the composition of the target. With PLD, the background gas pressure does not affect 
the passage or absorption of the laser, and the same system can be used to fabricate thin 
films composed of many materials by simply changing the background gas pressure. 
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Making multilayer materials can also be done rather easily with PLD, because 
different targets can be positioned under the laser beam. This is generally done with a 
computer-controlled target holder or carousel. 
PLD is a good technique for depositing extremely pure films while in most processes 
the film includes contaminants. For example, thermal and electron-beam evaporation 
use a container for the source material, and the fairly high temperatures needed to 
evaporate the source materials can also evaporate parts of the container, thereby 
contaminating the deposition process. 
The variety of coatings that can be deposited provides a range of solubilities with 
known consequences on the physico-chemical characteristics of the coatings. 
The species that were ejected in each laser pulse conformed the coating as they 
reached the substrate, which can also be heated to a fixed temperature. The X-ray 
diffractogram of the pure HA coating substantiated its high crystallinity. Its surface had 
a compact crystalline morphology with droplets [87, 92].  
Polymer and organic coatings have a wide range of pharmaceutical, bioengineering, 
and sensing applications. In fact, thin films of polymers and biomaterials are the basis 
of the chemoselective or biospecific layers that make possible the operation of most 
types of chemical and biochemical sensor systems, and gene and protein recognition 
microarrays. 
In the biomedical field, thin films of numerous types of biomaterials are essential in 
diverse areas such as tissue engineering, spatial patterning of cells, time-release drug 
delivery systems, antiinflammatory coatings for medical implants and implantable 
devices, and novel biocompatible adhesives for wound closure, eye repair, and nerve 
reconstruction. 
Attempts to deposit thin films of organic and polymeric materials by pulsed laser 
deposition (PLD) date back to the first report by Mith and Turner [96] who 
demonstrated the growth of thin films of fuchsine (an organic dye) and Ni-dimethyl 
glyoxime (a pigment used in paints and cosmetics). 
Despite this early report, little additional work was performed in PLD of organics and 
polymers for the next 20 years until Hansen and Robitaille demonstrated the use of 
pulsed ultraviolet (UV) lasers for depositing films of several polymers such as 
polyethylene, polycarbonate, polyimide, and poly(methylmethacrylate), or PMMA [93]. 
Their results showed an improvement of the laser ablation behaviour and film 
morphology with decreasing laser wavelengths. Indications were also observed that the 
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film quality is enhanced by working at laser energies near the ablation threshold of the 
polymers. However, they also noted a decrease in the molecular weight of all the films 
that they prepared. Since then, there has been a large number of reports on the use of 
PLD for growing thin films of many types of polymeric and organic materials.  
Despite the extensive list reported in the literature of polymer and biomaterials 
deposited by PLD, fundamentally the use of PLD for the deposition of organic and 
polymeric materials has provided, at best, mixed results. 
Despite the large number of variables explored in deposition parameter space by 
numerous research groups, the quality of the films produced by PLD has only been 
adequate for a very small number of systems. By using a pulsed UV laser to ablate the 
various organic and polymeric targets, it is not surprising that the resulting films will 
tend to show some degree of irreversible decomposition or damage. 
In fact, the question from early studies of polymer laser ablation has been whether the 
ablative decomposition takes place primarily through photochemical or photothermal 
pathways. Upon absorption of the UV pulse, the organic molecules are excited into 
high-energy electronic states that might result in direct bond dissociation, that is, 
photochemical, or instead decay through lattice vibrations with considerable heating of 
the surrounding molecules, that is, photothermal effects. 
Given the fact that in most organic materials the chemical bonds have energies well 
below the UV photon energies, some degree of photochemistry is expected to occur 
during the PLD process. However, the decomposition pathways are mainly determined 
by the chemical structure of the organic molecule itself. As a result, the products of the 
interaction between the UV photons and the organic or polymeric molecule tend to be 
extremely difficult to predict and thus control. 
Only for a small group of addition polymers such as poly(tetrafluoroethylene) (PTFE) 
and PMMA, the absorbed UV radiation causes the simple photothermal 
depolymerization of the starting material into its monomer building blocks, resulting in 
the reversible unzipping of the polymer chains . Blanchet’s work showed that under the 
appropriate conditions it is possible to deposit high-quality PTFE and 
poly(vinyfluoride) (PVF) thin films by PLD [94].  
More often than not, however, the interaction of the UV photons with the polymeric 
or organic molecules causes the loss or decomposition of functional groups, or in the 
case of condensation polymers the resulting photochemistry is responsible for the 
substantial modification of the starting material. 
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Such modifications might be acceptable for some applications, but in general, the use 
of lasers for depositing thin films of polymeric biomaterials requires more subtle 
approaches than those offered by PLD alone. 
 
 
 
 
Fig. 13 - PLD apparatus. 
 
 
1.3.2.2 Matrix Assisted Pulsed Laser Evaporation 
 
Laser processing of polymer and biomaterial thin films using traditional PLD is not a 
viable option for depositing organic coatings that faithfully replicate the properties and 
functionality of the starting materials. One approach that has shown great promise is 
known as matrix-assisted pulsed laser evaporation, or MAPLE. 
MAPLE is a recently developed thin film deposition technique, slightly different from 
PLD, particularly well suited for organic/polymer thin film deposition. In PLD, largely 
applied for inorganic thin film deposition, a pulsed laser beam is focused onto a solid 
target whose material is ablated from target and deposited on a nearby substrate. 
Although some addition polymers were successfully deposited, the PLD of addition 
polymers seems to proceed via a “depolymerisation-ablation of monomers-
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repolymerization” mechanism. This is clearly not possible in general for condensation 
polymers or other organic molecules. 
In MAPLE deposition technique the pulsed laser beam is focused on a target obtained 
as a frozen solution in a relatively volatile solvent of the molecules to be deposited. The 
advantage of MAPLE with respect to PLD technique is that a great part of the laser 
beam energy is transferred to the solvent and molecules to be deposited are ejected from 
the target mainly due to solvent vaporization. Such technique is therefore especially 
well suited for deposition of large molecules as in organic or polymeric compounds, 
whose structure may be damaged by direct laser irradiation (Figure 14) [95, 96]. The 
MAPLE process was developed in the late 1990s at the U.S. Naval Research Laboratory 
to provide a gentler pulsed laser evaporation process for functionalyzed polymers [94]. 
The MAPLE technique has been used successfully for depositing thin and uniform 
layers of chemoselective polymers, as well as organic compounds such as simple 
carbohydrates and their polymers [97]. 
MAPLE is a variation of conventional PLD. It provides, however, a less damaging 
approach for transferring many different organic and polymeric compounds that include 
small and large molecular weight species, from the condensed phase into the vapour 
phase. In MAPLE, a frozen matrix consisting of a solution of a polymeric compound 
dissolved in a relatively volatile solvent is used as the laser target. The solvent and 
solution concentration are selected so that the material of interest can dissolve to form a 
dilute, particulate-free solution and also so that the majority of the laser energy is 
initially absorbed by the solvent molecules and not by the solute molecules but is also 
very useful if the sample is suspended into the solvent. 
In MAPLE, the target usually contains 55 wt% of solute material, that is, polymer or 
biomaterial to be deposited. Thus, each polymer or biomaterial molecule is surrounded 
or shielded by a large amount of solvent or matrix. This configuration reduces both 
thermal and photonic damage to the polymer or biomaterial in solution during their 
laser-induced volatilization. Instead, the matrix molecules absorb the laser radiation and 
rapidly leave the surface as showed in the scheme reported below. 
Ideally, the solute molecules are entrained in the plume of matrix molecules leaving 
the frozen target due to collisions between the matrix and the embedded polymer or 
biomaterial molecules. 
Molecular dynamics simulations of the laser ablation of large molecules embedded 
into a low-molecular-weight matrix show in fact that as a result of the laser excitation, 
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clusters containing polymer molecules surrounded by matrix molecules are ejected 
together with the matrix material [98]. 
By careful optimization of the MAPLE deposition conditions, this process can occur 
without any significant polymer or biomaterial decomposition. The MAPLE process 
depletes the target of solvent and polymer in the same concentration as the starting 
matrix. 
The substrates are typically at room temperature during the MAPLE deposition 
process, but they can be heated slightly to anneal the growing film. Typically, an 
excimer laser is used (KrF at 248 nm or ArF at 193 nm) with 10- to 30-ns pulse width, 
at repetition rates between 1 and 20 Hz, focused to a 1 to 10 mm2 spot size on the target, 
although other types of lasers with wavelengths ranging from the visible to the infrared 
(IR) can be employed as well. The laser fluence at the target is typically set between 
0.01 and 0.5 J/cm2, depending on the solute material and solvent used. The depositions 
can be carried out at pressures ranging from vacuum to a few hundred millitorr and in 
the presence of inert or reactive background gases, in the same manner as conventional 
PLD. 
The matrix solution is prepared by dissolving the organic or polymeric material to be 
deposited in a solvent such as water, various types of alcohols, acetone, toluene, and so 
forth. To make a target, a few milliliters of the solution are flash frozen in a target die 
by submerging it in liquid nitrogen (LN2). Once frozen, the MAPLE target is mounted 
on a cryogenically cooled rotating target holder with the open die end facing the laser. 
In short, the MAPLE processing parameters are: composition of the target matrix, target 
and substrate temperature, target-to-substrate distance, type of background gas and 
pressure, laser wavelength, laser fluence, and laser repetition rate. 
When a substrate is positioned directly in the path of the plume, a coating starts to 
from the evaporated solute molecules, while the volatile solvent molecules, which have 
very low sticking coefficients, are evacuated by the pump in the deposition chamber. 
One advantage of the MAPLE process is that it can easily be combined with 
noncontact shadow masks to limit the deposition to only those required areas on a 
substrate. 
This is important for fragile substrates and is much less time-consuming than 
subsequent removal by patterning and etching. Furthermore, many polymer and organic 
coatings will not survive the solvents used to wash off the resists making them 
incompatible with standard lithographic processes. In such cases, MAPLE deposition of 
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the polymer or organic through a shadow mask might be the only way to deposit 
discrete thin-film structures of these materials. 
The MAPLE process has been used successfully to deposit polymer films through 
masks with features in the micron. This capability is very important for the manufacture 
of sensor arrays and electronic devices. 
Despite the great success achieved with the MAPLE technique for the deposition of 
polymers and biomaterials, this process is not without certain important drawbacks. 
First, the typical deposition rates that can be achieved with MAPLE are about an order 
of magnitude lower than those for conventional PLD. 
Given that most of the organic compounds to be deposited have a very large UV 
absorption cross section, it is necessary for the matrix solution to contain low 
concentrations (2-5 wt%) of the polymer or biomaterial solute molecules in order to 
minimize their interaction with the UV photons. 
Finally, the solvent molecules might be subject to photochemical reactions during 
their interaction with the laser pulse, which in some cases can result in the generation of 
highly reactive radicals that can alter the chemical structure and functionality of the 
solute polymer or biomaterial being deposited. 
Another aspect that must be taken into consideration when using MAPLE is the 
resulting film surface morphology. 
Under certain conditions, that is, low laser fluence, low laser repetition rate, low 
solute concentration in the matrix, and/or lower temperature of the target matrix, it is 
possible to produce very smooth and uniform coatings with MAPLE. More often than 
not, however, the surface morphology of the films tends to be rough and in some cases 
large droplets are present as well. 
The film roughness not only depends on processing conditions but also on the type of 
polymer or organic being deposited and in the case of many biomaterials might not be 
modifiable due to the characteristic intrinsic arrangements of the molecular chains. For 
some applications, such as in biosensors, higher surface areas resulting from the rough 
film morphology might be desirable since they increase the area for analyte binding. 
The rough protein films that can be generated by MAPLE can potentially increase the 
detection capability of a biosensor by increasing the active protein area exposed to a 
particular analyte. 
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Fig. 14 - MAPLE apparatus. 
 
 
 
 
 
 
Fig. 15 - Scheme of MAPLE process. 
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1.3.3 Bone Cements 
 
Calcium phosphate bone cements first appeared in the literature during the 1980s and 
these materials offer the potential for in situ moulding and injectability. There are a 
variety of different combinations of calcium compounds which are used in the 
formulation of these bone cements but the end product is normally based on a calcium 
deficient HA. 
The development of calcium phosphate cements as a class of viable biomaterials has 
increased interest in their use as artificial hard tissues. One of the earliest CaPs 
investigated was based on the hydrolysis of -tricalcium phosphate. -TCP was shown 
to hydrate to a calcium-deficient hydroxyapatite (CDHA) in dilute aqueous solutions. 
This calcium phosphate is unique because it can hydrolyze to form a cement. The rate 
of -TCP hydrolysis has been observed to increase with temperature and decrease with 
increasing pH. Hydrolysis of -TCP to CDHA occurs by a mechanism involving two 
steps. The first step occurred within the first hour and resulted in high initial pH values 
commensurate with a spike in the calcium concentration. This initial step was a result of 
slight compositional non-homogeneities attributable to synthesis conditions initially 
employed. The elevated pH also resulted in a reduction of the rate of hydrolysis. The 
second reaction step resulted in the bulk of hydrolysis. The activation energies for these 
steps were determined; they indicate a nucleation and growth mechanism. The 
microstructure of the resulting CDHA differed greatly from that produced by the 
DCPD-TetCP reaction at equivalent temperatures. In particular, crystallites are much 
larger, resulting in lower surface areas, and the hydroxyapatite formed is more 
crystalline that that produced by reaction of DCPD with TetCP at equivalent 
temperatures. This difference is attributable to the slower rate of TCP hydrolysis 
combined with the absence of the formation of ACP as an intermediate. The CDHA 
crystallites grew perpendicular to the -TCP surface, thus minimizing the formation of a 
diffusion barrier. Understanding the factors influencing the hydrolysis of calcium 
phosphate salts to apatites by cement reactions is essential in controlling the setting 
times and times to complete reaction. The properties must be understood and controlled 
if these types of materials are to be used in vivo applications. The crystallite size, 
morphology, and the crystallinity of CDHA from -TCP hydration should change its 
resorption characteristics when compared with HA formed by other techniques [99, 
100]. 
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 1.3.4 Scaffolds 
 
Scaffolding is a temporary framework used to support living matters in the 
construction or repair of large structures. 
Scaffolds are largely used for tissue engineering and regenerative medicine. In 
particular, scaffolds for osteogenesis should mimic bone morphology, structure and 
function in order to optimize integration into surrounding tissue. 
The development of the new technologies of bone tissue engineering required the 
production of bioresorbable macroporous scaffolds.  
One of the most promising approaches to the problem of bone regeneration and repair 
is bone tissue engineering (BTE). To guide in vitro or in vivo tissue regeneration, it is 
necessary to obtain appropriate scaffold materials, which satisfy all the goals required: 
osteoconductivity, controlled degradation, mechanical properties, formability, etc. 
Moreover, one of the main characteristics that is required in a BTE scaffold is a high 
interconnected macroporosity, to ensure cell colonisation and flow transport of nutrients 
and metabolic waste. In general, it is accepted that the pore size should range between 
100 and 400 mm. To this end, several porous ceramic manufacturing techniques have 
been proposed, such as hydrothermal exchange from corals, the inclusion of porogenic 
volatile or soluble substances, impregnation and gel-casting of foams, dual phase 
mixing, or solid free-form fabrication among others. However, the majority of these 
methods are based on the production of high temperature apatites, which are known to 
be hardly resorbable in normal physiological conditions, and some of the routes 
presented required complex processes of preparation, or the addition of second phases, 
which need to be eliminated to create the porosity even by sintering [97, 98]. 
An alternative route was recently presented to develop macroporous scaffolds at low 
temperature from calcium phosphate cements (CPCs). In this case, the consolidation of 
the porous structures is expected to be attained not by sintering, but through a low 
temperature setting reaction, and specifically through the entanglement of the crystals 
produced as a result of a dissolution-precipitation reaction. 
This approach has several advantages: first of all, the cementing reaction takes place 
at low temperature and therefore the final product is a low temperature precipitated 
hydroxyapatite, chemically more similar to the biological apatites, and with a much 
higher specific surface than that of a sintered hydroxyapatite. All these factors 
contribute to bring this material a higher reactivity, as compared to a ceramic 
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hydroxyapatite. In addition, the low temperature processing allows the introduction of 
proteins or different kinds of drugs into the material (for example, antibiotics, 
antiinflamatory or anticancer drugs). In second place: combination of intrinsic 
microporosity and introduced macroporosity, guarantees the interconnectivity between 
the macropores introduced into the cement, at least in a higher amount than that 
obtained in high temperature sintered materials. Finally, the processing techniques are 
simpler, and less expensive than those involved in the fabrication of high temperature 
porous ceramics.  
Moreover, as bone is a complex material composed of nanocrystals of a basic calcium 
phosphate deposited within an organic matrix which is mainly type I collagen, it is not 
surprising that a lot of research has been performed on collagen, and on its derivative, 
gelatin. Gelatin is obtained by thermal denaturation or physical and chemical 
degradation of collagen through the breaking of the triple- helix structure into random 
coils. With respect to collagen, gelatin does not express antigenicity under physiological 
conditions, it is completely resorbable in vivo and its physicochemical properties can be 
suitably modulated; furthermore it is much cheaper and easier to obtain in concentrated 
solutions. The functional properties of gelatin are related to its chemical characteristics. 
In particular, the gel strength, viscosity, setting behaviour and melting point of gelatin 
depend on its molecular weight distribution and amino acid composition. Bone tissue 
formation is enhanced by scaffolds because of the presence of pores, which allow 
migration and proliferation of osteoblasts and mesenchymal cells, as well as 
vascularization. In addition, a porous surface improves mechanical interlocking between 
the implant biomaterial and the surrounding natural bone, providing greater mechanical 
stability at this critical interface. 
Porosity can be produced with the same methods as those used for polymeric 
scaffolds, which have been intensively studied for decades to provide implantable 
devices for tissue regeneration. The methods include fiber bonding, melt molding, 
solvent casting/particulate leaching, gas foaming/particulate leaching, phase separation, 
high-pressure processing, electrospinning and rapid prototyping. The formulations 
proposed for porous gelatin scaffolds with ceramic particles include -tricalcium 
phosphate (-TCP) and HA. These porous scaffolds usually exhibit poor mechanical 
properties and are easily degraded, due to the high solubility of gelatin in aqueous 
solution. Mechanical, as well as biological stability is increased by gelatin crosslinking, 
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though this can also decrease biocompatibility because of the cytotoxic reaction of 
crosslinking agents such as glutaraldehyde. 
Lately, a relatively soluble and easily hydrolysable calcium phosphate, -tricalcium 
phosphate [-Ca3(PO4)2, -TCP], has been used to prepare porous scaffolds based on 
gelatin. The composite scaffolds were obtained by freeze–drying gelatin foams at 
different -TCP contents and it’s possible to vary the composition in order to modulate 
their morphological and mechanical properties [101]. 
 
1.3.4.1 Drug Delivery 
 
Another way to treat bone disorders is by using local drug delivery devices. The local 
delivery of drugs should greatly reduce any systemic toxicities and side effects of 
parenteral administration. A higher drug concentration in relevant tissues can be 
administered by these local drug delivery devices, therefore an improved efficacy can 
be expected [102]. 
There has been considerable interest in recent years in developing controlled or 
sustained drug delivery systems by using biopolymers. Controlled or sustained release 
drugs provide many advantages in comparison with conventional forms including 
reduced side effects, drug concentration kept at effective levels in plasma, improved 
utilization of drug and decrease the dosing times. 
Targeted drug delivery is essential to modern medicine in which specifically designed 
and effective drugs are employed to work on selected tissues, cells, and cellular 
structures. The use of microspheres based therapy allows drug release to be carefully 
tailored to the specific treatment site through the choice of appropriate formulation 
variables. The design of metal oxide/polymer hybrid nanocapsules has attracted much 
attention in the last few years, due to their wide range of applications, from catalysis to 
controlled release devices. Many of these nanocomposites are designed as polymer-
core/oxide-shell materials, although oxide-core/polymer-shell as well as bi-continuous 
structures were also described. 
Preparation of core–shell particles can take place following a one-step process, based 
on the self-assembly of organic and inorganic components, or a two-step process, i.e. 
the deposition of the shell on a pre-formed core particle.  
In particular, inorganic coatings of polymeric particles have been realized by reactions 
that utilize specific functional groups on cores’ surfaces in order to induce the inorganic 
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phase precipitation. The inorganic shells obtained in this way include silica, basic 
yittrium carbonates and metal oxides [103]. Gelatin is a protein produced by partial 
hydrolysis of collagen extracted from the bones, connective tissues, organs, and some 
intestines of animals such as the domesticated cattle, and horses. The natural molecular 
bonds between individual collagen strands are broken down into a form that rearrange 
more easily. Gelatin is an irreversibly hydrolyzed form of collagen [104]. 
 The main limitation of gelatin for the preparation of sustained release systems arises 
from its rapid dissolution in aqueous environments leading to fast drug release at body 
temperature. In order to overcome this problem, chemical cross-linking procedures 
giving rise to the formation of non-soluble networks have to be taken into consideration 
[105]. 
 The main characteristics of gelatin involve the presence of acidic and basic functions 
like all biopolymers. It is also able to form triple helixes in aqueous solution at low 
temperature and this is not observed in synthetic polymers [106 - 108]. The rate of 
formation of the triple helixes depends on many factors, such as the presence of 
covalent bonds, the molecular weight of gelatin and its concentration in the solution, the 
presence of amminoacids [107 - 109]. 
Moreover it interacts in a specific way with water, different from that one followed by 
synthetic hydrophilic biopolymers. This characteristic controls the structural and 
physic-mechanical properties of gelatin when in solid state. The capacity to absorb 
water depends on pH value and it increases on increasing the ionization of those groups 
that can dissociate. From the comparison between a collagen film and a gelatine film 
with an helycoidal or disordered structure, it is possible to conclude that the higher is 
the rate of molecular order inside the protein, the higher is the capacity to absorb of 
water vapour at almost all the humidity’s values of the atmosphere. 
The water bonded with the protein is in part absorbed by the polar groups of the 
macromolecules out of the helycoidal fragments, thus improving their stabilization. 
In particular conditions of temperature, pH and solvent values, gelatin 
macromolecules can represent sufficient flexibility to realize a great quantity of 
conformations, so as to vary all the gelatin properties that depends on its structure. 
Gelatin is the only one hydrocolloid substances that forms thermoreversible films with 
a melting point similar to that of the human body. 
At molecular level, the gelification of gelatin solutions is promoted by a 
conformational change, from coil to helix [110], where three portions of the chain can 
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associate by hydrogen bonds. The characteristic parameters of the triple helixes are 
almost the same at those of collagen fibres [111]. The main differences between the 
original and rinaturate triple helixes consist first of all in the length of the helix  and also 
in the supramolecular arrangement of these units. Several experiments showed that 
collagen molecule can’t be created in the gel state because the  chains hardly can 
perfectly interact [112]. 
So, in gelatin gels, the only ordered regions are the sequences with a limited length of 
triple helixes, randomly distributed in space: the tendency to be side by side observed in 
the dry state disappear when water is added. The considerable swelling of the fibres is 
inducted by the possibility to space the triple helixes. 
The supramolecular arrangement of collagen molecules in native fibres is absent in 
gelatin gels where portions of renaturated triple helixes act like junctions and form a 
tridimensional structure. This structure and the physical properties of gelatin gels deeply 
depend from their renaturation level, that on its own is influenced by temperature, type 
of gelatin and the utilized solvent. Because of its ability to form transparent and 
resistant gels, and also flexible and thermoreversible films, gelatin finds several 
applications. In fact, it is used in alimental processes as base for gummy cakes, as meat 
and fruits preservative, in powder components and as whitening for beer and wine; its 
industrial applications include capsules for drugs, biomaterials, coatings of 
photographic plates, paper production. 
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2. Aim of the Research 
 
A material for hard tissue replacement must be able to create a bond with the host 
living tissue [113]. This requirement is better fulfilled the more the synthetic material 
resembles the biological one in composition, structure, morphology, and functionality 
[114]. This approach is included in the biomimetics principles, which is addressed to the 
design and development of new synthetic materials using strategies adopted by living 
organisms to produce biological materials. In particular, biomineralized tissues are often 
sophisticate composite materials, in which the components and the interfaces between 
them have been defined and optimized, and that present unusual and optimal chemical-
physical, morphological and mechanical properties. Moreover, biominerals are 
generally produced by easily traceable raw materials, in aqueous media and room 
pressure and temperature, that is with cheap process and materials. Thus, it is not 
surprising that the idea to mimic those strategies proper of Nature has been applied to 
several areas of applied sciences, in particular to the synthesis of new materials for the 
substitution and repair of skeletal tissue. 
Due to its similarity with bone mineral and to its high biocompatibility and 
bioactivity, synthetic HA has generated a great deal of interest in relation to hard tissue 
applications. However, bone apatite differs from synthetic stoichiometric HA for 
several aspects, namely small crystal dimensions, poor degree of crystallinity, and non 
stoichiometry due to the presence  of a variety of foreign ions. Biomimetics’ approach 
to the development of biomaterials for bone tissue repair shifted the attention from 
stoichiometric, highly crystalline HA, towards nanocrystalline apatite (also called 
biomimetic apatite), and further more resorbable calcium phosphate, such as 
octacalcium phosphate (OCP), -tricalcium phosphate (-TCP) and dicalcium 
phosphate dihydrate (DCPD), that can easily transform into nanocrystalline apatite [115 
- 118]. The research activity of this PhD thesis is addressed to study the interaction 
between calcium phosphates and biologically active ions and molecules in order to 
obtain new materials with potential applications as biomaterials for hard tissue 
substitution and repair. 
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The research program involves the following lines: 
 
1)  Modified calcium phosphates. 
 
  a) hydroxyapatite and octacalcium phosphate, modified by the 
introduction of biological interesting ions or molecules, such as strontium, magnesium, 
manganese and bisphosphonates, have been synthesized and characterized in order to 
put into evidence the structural and morphological modifications induced by the 
additives. 
  b) strontium ion was also investigated in order to clarify its influence on 
the reaction of -TCP which is the basis of the hardening reaction of bone cements. 
Strontium ion delays the reaction kinetics but it is englobed in the powder so that the 
final cement results more biocompatible. 
 
 2) Deposition of modified calcium phosphates on metallic substrates. 
 
Some of the synthesized calcium phosphates have been used to coat metallic 
substrates using PLD and MAPLE methods in order to improve the biological 
performance of the implants: 
   
  a) hydroxyapatite at increasing Sr content, up to 7 atom % has been 
deposited by means of Pulsed Laser Deposition on etched Titanium substrates; 
  b) alendronate-hydroxyapatite nanocrystals at different bisphosphonate 
content have been successfully deposited on Titanium substrates using Matrix Assisted 
Pulsed Laser Evaporation. 
The chemistry, structure and morphology of the coatings have been characterized, 
before in vitro tests with bone cells. 
 
 3) Core-shell particles for drug delivery. 
 
Scaffolds are largely used for tissue engineering and regenerative medicine, as well as 
for drug delivery. Integration into surrounding tissue is better achieved the more the 
scaffold mimics bone morphology, structure and function. As bone is a complex 
material composed of nanocrystals of a basic calcium phosphate deposited within an 
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organic matrix which is mainly constituted of type I collagen, core–shell particles based 
on the self-assembly of gelatin and calcium phosphates as main components could fulfil 
this requirement. On this basis, the preparation of gelatin microspheres stabilized with 
dialdehyde alginate and coated with a uniform layer of calcium phosphate has been 
optimized. Aspirin has been used as a model drug to test the performance of these 
materials as drug release devices. 
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3. Materials 
 
3.1 Syntheses 
 
 
3.1.1 Sr-substituted Hydroxyapatite 
 
(Ca–Sr) hydroxyapatites (Ca–Sr–HA) with Sr/(Ca + Sr) molar ratios in the range from 
0 to 1 were synthesized in N2 atmosphere using 50 mL solutions with different Sr/(Ca + 
Sr) ratios prepared by dissolving the appropriate amounts of Ca(NO3)2  4H2O and 
Sr(NO3)2 in CO2-free deionized water and adjusting the pH to 10 with NH4OH. 
The total concentration of [Ca2+] + [Sr2+] was 1.08 M. The solution was heated at 90 
°C and 50 mL of 0.65 M (NH4)2HPO4 solution, pH 10 adjusted with NH4OH, was 
added dropwise under stirring. The precipitate was maintained in contact with the 
reaction solution for 5 hours at 90 °C under stirring, then centrifuged at 10000 r.p.m. for 
10 minutes and washed repeatedly with distilled water. The product was dried at 37 °C 
overnight [54]. 
 
 
3.1.2 Alendronate-Hydroxyapatite Nanocrystals 
 
The syntheses of AL–HA nanocrystals were carried out using a method recently 
developed. Briefly, 50 mL of 1.08M Ca(NO3)2  4H2O solution at pH adjusted to 10 
with NH4OH was heated at 90 °C in N2 atmosphere and 50 mL of 0.65M (NH4)2HPO4 
solution, pH 10 adjusted with NH4OH, was added dropwise under stirring. Soon after 
completion of the phosphate addition, the alendronate solution was dropped under 
stirring in the reaction vessel. The precipitate was maintained in contact with the 
reaction solution for 5 hours at 90 °C under stirring, then centrifuged at 10,000 r.p.m. 
for 10 min and repeatedly washed with CO2-free distilled water. The product was dried 
at 37 °C overnight. Four series of samples (HA, HA–AL7, HA–AL14, and HA–AL28) 
were prepared using alendronate concentrations of 0, 7, 14 and 28 mM [119]. 
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  3.1.3 Substituted OctaCalcium Phosphate  
 
Octacalcium phosphate was synthesized by dropwise addition of 250 mL of 0.04 M 
Ca(CH3COO)2 (Carlo Erba) into 750 mL of a phosphate solution containing 5 mmol of 
Na2HPO4 (Carlo Erba) and 5 mmol of NaH2PO4 (Carlo Erba) maintained at 60°C, 
starting pH was 5 by adding H3PO4 [120]. 
The precipitate was stored in contact with the mother solution for 10 min, filtered, 
repeatedly washed with bidistilled water and dried at 37°C. The synthesis of substituted 
OCP was carried out by adding Sr(CH3COO)2, Mn(CH3COO)2, Mg(CH3COO)2 to 
Ca(CH3COO)2 in the appropriate ratios so as to maintain the right molarity. 
 
 
3.1.4 α-TriCalcium Phosphate 
 
-TCP was obtained by solid-state reaction of a mixture of CaCO3 and CaHPO4 · 
2H2O in the molar ratio of 1:2 at 1300°C for 5 hours [121]. The solid product was 
ground before being submitted to hydrolysis reaction. 
 
 
3.2 Thin films deposition 
 
Disk-shaped (diameter = 15 mm, thickness = 0.5 mm) Ti substrates were 
mechanically polished and subsequently submitted to acid etching to obtain an extended 
active surface.  
 
 
3.2.1 Pulsed Laser Deposition  
 
For PLD experiments disk-shaped tablets with 1 gram of the powder were prepared 
simply pressing it under 15 tons for a few minutes. The tablets were then subjected to 
the laser beams. 
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3.2.2 Matrix Assisted Pulsed Laser Evaporation 
 
For MAPLE experiments a concentrated suspension in H2O of the sample were 
prepared. It was stirred for 10 minutes to reach homogeneity. Then it was frozed with 
liquid nitrogen and after that it was subjected to the laser beams.  
 
 
3.3 Hydrolysis 
 
Hydrolysis of α-TCP was carried out in bidistilled water at different concentrations of 
SrCl2 · 6H2O from 2 to 20% (calculated with respect to the Calcium atoms in the α-TCP 
powder: [Sr/(Ca + Sr)]  100 ratios from 2 to 20). The reaction of hydrolysis was 
performed on 100 mg α-TCP/50 mL solution at 37 or 60°C, without stirring, for 
different periods of time, up to 35 days. Then the products were filtered, repeatedly 
washed with double distilled water and dried at 37°C.  
In order to increase the phase conversion speed, the hydrolyses were also performed 
by adding 5 mg of DCPD to the α-TCP powder. 
Alternatively, the hydrolysis of α-TCP was studied in solutions containing gelatin. 
Type A gelatin (280 Bloom, Italgelatine S.p.A.) from pig skin was used. α-TCP was 
soaked at 37°C in solutions at gelatin concentration of 0.1, 0.5 and 1% wt. The co-
presence of Sr2+ ions was also evaluated, even in the presence of DCPD. 
 
 
3.4  Microspheres 
 
 
3.4.1 Alginate dialdheyde 
 
Alginate dialdheyde (ADA) was obtained by a partial oxidation of sodium alginate 
(Carlo Erba) by using sodium metaperiodate (Fluka). 10 grams of sodium alginate were 
added to 50 mL of ethanol and then this solution was added to a metaperiodate solution 
characterized by 0,95 mol every sodium alginate mol in 50 mL of distilled water. 
This mixture was maintained stirring at 25°C for 6 hours in a dark ambient so as to 
obtain dialdeide alginate (ADA) oxidate at about 50-60%. After the necessary time the 
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mix was dialyzed with 2,5 L of H2O mQ for 48 hours refreshing the water repeatedly so 
as to obtain the complete exclusion of the oxidant agent. This was demonstrated by 
adding 0,5 mL of the dialysed product to 0,5 mL of silver nitrate 1% solution and 
verifying that no precipitate was observed. At the end the dialysed product was freeze-
dried [122]. 
 
  
3.4.2 Gelatin microspheres cross-linked with Alginate 
Dialdheyde and Calcium 
 
Cross-linking of gelatin was performed before starting the reaction of preparation of 
the microspheres, by addiction of 5 mL of calcium acetate 0.2 M to 5 mL of aqueous 
solution containing gelatin 10% w/v and ADA 3% w/w [51]: after 2 minutes of 
magnetic stirring, 5 mL of the mixture were added to the oil phase at 40°C. The mixture 
was mechanically stirred at 400 r.p.m. for 5 minutes, then very rapidly made cold by 
using ice for 10 minutes under stirring. 50 mL of acetone at 5°C were added to 
dehydrate the microspheres, slowly stirring (200 r.p.m.) for a couple of minutes. The 
mixture was then filtered under vacuum and washed three times with cold acetone so as 
to remove oil residues. Then it was air dried. 
 
 
3.4.3 Synthesis of the inorganic shell 
 
The coating of gelatin microspheres with calcium phosphates was obtained by direct 
synthesis. After the preparation of gelatin microspheres when the reaction medium is 
maintained at 0°C by the use of ice, 7,5 mL of sodium phosphates solution (0.2 mmol 
Na2HPO4  12H2O, 0.2 mmol NaH2PO4  2H2O, 0,084 g sodium polyacrylate) at pH 5 
for H3PO4 were added. The solution was slowly stirred for a couple of  minutes. Then 5 
mL of a calcium acetate 0.16 M were dropped in the reaction solution in 5 minutes and 
after 10 minutes the speed of stirring was decreased and 50 mL of cold acetone were 
added. The product was then filtered under vacuum and three times washed with 
aliquots of 25 mL of acetone at 5°C. Then it was air dried. 
To make easier the precipitation of calcium phosphate on the microspheres’ surfaces 
and form a complete and homogeneous coating several different tests have been 
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performed. Many parameters have been changed, such as pH value, sodium phosphates 
concentration NaPA concentration and temperature. A regular and homogeneous 
coating of amorphous calcium phosphate was obtained at pH 5. 
 
 
3.4.4 Aspirin-loaded microspheres 
 
Acetyl salicylic was chosen as a model to test the drug release from gelatin 
microspheres. It is, in fact, soluble in aqueous media (10 mg/L mL H2O at 20°C) and for 
this reason as demonstrated by the experiments, it doesn’t badly influence the gelatin 
microspheres preparation. 50 mg of aspirin was dissolved before starting the reaction in 
the same water in which gelatine was dissolved so as to be automatically contained 
inside the microspheres in an homogeneous way. The procedure adopted was the same 
optimized for the preparation of gelatin microspheres previously described. 
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4. Methods 
 
 
4.1 X-Ray Diffraction 
 
 
X-ray diffraction analysis was carried out by means of a PANalytical X’Celerator 
powder diffractometer equipped with a monochromator in the diffracted beam. Cu Ka 
radiation was used (40 mA, 40 kV). The 2 range was from 3° to 60° at a scanning 
speed of 0.75°/min. In order to evaluate the coherence lengths of the crystals and to 
perform the line profile analysis, further X-ray powder data were collected in the 2 
range from 15° to 100° in the step scanning mode with a fixed counting time of 10 s for 
each 0.030°/step. 
For Rietveld analysis, the diffractometers were recorded in the range of 2 from 3° to 
60° slower than before, in order to obtain as precise as possible peaks positions 
(0.03°/step, 200 s/step). 
X-ray diffraction analysis of thin films deposited on Ti substrates was carried out by 
means of a PANalytical X’Pert PRO powder diffractometer. CuKa radiation was used 
(40 mA, 40 kV). Data were obtained in the range of 2 from 3° to 60° (0.02°/ step, 10 
s/step). 
 
4.1.1 Scherrer analysis 
 
The line broadening of the 002 and 310 reflections was used to evaluate the length of 
the coherent domains (hkl) along the c-axis and along a direction perpendicular to it.  
h k l values were calculated from the widths at half maximum intensity (b1/2) using the 
Scherrer equation [123]: 
 
K ⋅ λ 
τhkl   =   
β ⋅ cosθ 
 
where k is the wavelength, h the diffraction angle and K a constant depending on 
crystal habit (chosen as 0.9). The silicon standard peak 111 was used to evaluate the 
instrumental broadening. 
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4.1.2 Rietveld refinement analysis 
 
The DEBVIN program [124 - 126], essentially implemented on Rietveld routine 
[127], was used to refine the structures of the samples. The space group (P63/m, No. 
176), the cell parameters, the atomic positions and the thermal parameters of CaHA are 
introduced as the initial structural model. For SrHA, the data of the single crystal were 
used [128]. The phosphate group was considered as a rigid body. The background is 
treated as an empirical segmented line where the heights of the six nodes are free 
variables. The peaks were fitted by using a Pearson VII function. The half width of the 
diffraction peaks as a function of 2 was evaluated by the formulation of the Caglioti 
model [129]. 
The possibility to refine the mean crystallite size parallel to crystallographic axes was 
taken into account. Rietveld refinement was performed in several stages, the parameters 
obtained in each step being deferred in the following one. 
In the first cycles the scale factor and the background were refined. The refinement of 
the other parameters is in the following order: zero shift, profile parameters, asymmetry 
parameter, cell parameters, crystallite anisotropy. The refinements of the occupancy 
factors and of the coordinates were tested at the latest stages of the procedure, starting 
with those of the two metal sites. The atomic displacement parameters in the form of 
Biso were refined but not simultaneously with occupancy factors, because of their 
correlation. The total number of variables refined was 22. 
 
 
4.2 Fourier Transform Infra-Red Spectroscopy 
 
 
For the IR adsorption analysis, 1 mg of the powdered samples was carefully mixed 
with KBr (250 mg, infrared grade) and pelletized under a pressure of 10 tons for 2 min. 
The pellets were analyzed using a Nicolet 380 FTIR spectrophotometer to collect 32 
scans in the range 4000 – 400 cm-1 at a resolution of 4 cm-1. 
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4.3 Atomic Absorption Spectroscopy 
 
Calcium and strontium contents were determined using a GBC 901 atomic absorption 
spectrophotometer ((Ca) = 422.7 nm; (Sr) = 460.7 nm). The samples were diluted to 
an appropriate volume with 10% lanthanum in 50% HCl, in order to suppress 
interferences. 
 
 
4.4 Scanning Electron Microscopy 
 
 
Morphological investigations of the synthesized products were conducted using a 
Philips XL-20 Scanning Electron Microscope. The samples were sputter coated with 
gold for 2 minutes and 30 seconds before examination. 
 
 
4.5 Transmission Electron Microscopy 
 
 
For TEM investigations, a small amount of powder was dispersed in ethanol and 
submitted to ultrasonication. A drop of the calcium phosphate suspension was 
transferred onto holey carbon foils supported on conventional copper microgrids. A 
Philips CM 100 transmission electron microscope operating at 80 kV was used. 
  
 
4.6 Surface Area Analysis by Gas Adsorption (BET) 
 
 
The surface area was measured using a Carlo Erba Sorpty 1750 BET analyzer using 
constant volume N2 absorption with desorption at 100 °C [130]. 
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4.7 Pulsed Laser Deposition 
 
 
The films were pulsed-laser deposited on etched Ti substrates using an UV KrF* 
excimer laser source (k = 248 nm,  ~ 7.4 ns). Prior to each deposition, the reaction 
chamber was evacuated down to a residual pressure of 10-4 Pa. Films were deposited in 
50 Pa water vapour flux on substrates heated to 400 °C. The substrates were placed 
parallel to the targets, 4 cm away from them. Fluence was set at 2.4 J cm-2, and 25,000 
subsequent laser pulses were applied at a frequency repetition rate of 2 Hz for the 
deposition of each film. The as-deposited samples were submitted to annealing 
treatments in water vapour and ambient pressure for 6 hours at the same temperatures as 
those applied during deposition. The average thickness of the obtained structures, as 
measured by profilometry, was ~1 	m. 
 
 
4.8 Matrix Assisted Pulsed Laser Evaporation 
 
 
The procedure just described above for PLD was adopted for MAPLE too. Only a few 
characteristic parameters are different. In fact, in MAPLE the fluence is deeply lower 
than that in PLD being only 0,75 J cm-2 because of the nature of compounds treated. 
Moreover, the temperature of the substrate is only 30 °C and the pressure inside the 
reaction chamber 10-1 torr. 
 
 
4.9 UV – Phosphorous, Gelatin and Drug Release 
Determination 
 
 
Phosphorus content in Sr-HA was determined spectrophotometrically in 
molybdovanadophosphoric acid using a Varian Cary50Bio instrument ( = 400 nm). 
Bicinconinic acid test allowed to determine the protein concentration of the solution 
by a colorimetric technique [131]. 50 mg of gelatine microspheres were immersed in 5 
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ml of phosphate buffer solution (PBS) pH 7.4 at 37 °C; several fractions of release 
solution were drawed, refreshing the PBS solution after every drawing, the gelatin 
concentration was analyzed. A test solution was prepared with cuprum(ii)sulfate penta-
hydrate and an excess of bicinconinic acid so as to obtain a final ratio of 1:50 v/v. 200 
	L of the release solution were added to 2 mL of test solution and with PBS. The final 
volume was 5 mL. After 1 hour and 30 min at ambient temperature the absorbance of 
each of these solutions was measured by using a Cary 50 spectrophotometer at 562 nm. 
The gelatine concentration was evaluated by a calibration curve, constituted by the 
results of standard solutions in the concentration range of 5-100 mg of gelatine/100 mL 
PBS.  
200 	L of the same solution were diluted in PBS to the final volume of 5 mL and 
analyzed by measuring the absorbance at 297 nm so as to obtain the drug released 
percentages. 
 
 
4.10 Cell Culture 
 
 
4.10.1 Osteoblast culture 
 
MG63 human osteoblast-like cells were cultured in Dulbecco’s modified Eagle’s 
medium (DMEM, Sigma, UK), supplemented with 10% fetal bovine serum (FBS) and 
antibiotics (100 U mL-1 penicillin, 100 mg mL-1 streptomycin). 
The cells were detached from culture flasks by trypsinization, and centrifuged. Their 
number and viability were determined by the trypan blue dye exclusion test. 
MG63 osteoblast-like cells were plated at a density of 2  104 cells mL-1 in 24-well 
plates containing sterile samples of reference sample and samples of substitutes 
compounds. The same concentration of cells was seeded in empty wells as a control 
(CTR). Plates were cultured in standard conditions at 37 °C and 95% humidity, and 5% 
CO2. After 24 hours, the medium was replaced with DMEM supplemented with b-
glycerophosphate (10-8 nM) and ascorbic acid (50 	g mL-1) to activate the osteoblasts. 
To stimulate the production of osteocalcin, the culture medium was enriched with 
1,25(OH)2D3 48 hours before the end of the experiment. 
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After 1 hour of culture, phalloidin staining was performed to assess cell adhesion and 
colonization of the samples. The cultures were washed in PBS and fixed in a solution of 
4% formaldehyde in PBS for 15 min at 37 °C. The samples were then permeabilized in 
0.5% Triton X-100 for 15 min and washed in PBS. A FITC-conjugate phalloidin 
solution (1:100 in PBS) was added for 30 minutes at 37 °C. 
After washing, the samples were examined by fluorescence microscopy. 
The Cell Proliferation Reagent WST-1 test was carried out to assess cell proliferation 
and viability at fixed experimental times (7, 14 and 21 days): 100 	L of WST-1 solution 
and 900 	L of medium (final dilution: 1:10) were added to the cell monolayer, and the 
multiwell plates were incubated at 37 °C for the next 4 hours. Supernatants were 
quantified spectrophotometrically at 450 nm using a reference wavelength of 625 nm. 
The results of WST-1 were reported as optical density (OD). 
Finally, at the end of experimental times the supernatant was collected from all wells 
and centrifuged to remove particulates, if any. Aliquots were dispensed in Eppendorf 
tubes for storage at -70 °C and assayed for type I collagen (CICP, Procollagen-C 
Enzyme Immunoassay Kit, Metra Biosystem, CA), osteocalcin (OC, Enzyme 
Immunoassay Kit, Bender MedSystems, Vienna), osteoprotegerin (OPG, Immunoassay 
Kit, Bender MedSystems, Vienna), TNFrelated activation-induced cytokine receptor 
(TRANCE, Immunoassay kit, Bender MedSystems, Vienna). Alkaline phosphatase 
activity (ALP, kinetic assay, Biosystems SA, Barcelona), was checked on supernatants 
immediately after collection. All the measured concentrations and activities were 
normalized by cell number to take cell growth differences into account. 
 
 
4.10.2 Isolation of mononuclear cells for osteoclast culture 
 
Peripheral human blood was obtained from healthy adult volunteers and collected in 
heparinated tubes, to prevent clotting. Density gradient centrifugation was used to 
separate mononuclear cells from the other elements of blood. Briefly, a volume of 
peripheral blood was diluted 1:1 with pre-warmed PBS and carefully layered on an 
equal volume of Histopaque 1077 in a 50 mL tube. The tube was centrifuged with 400g 
at 20 °C for 30 min. After centrifugation, the mononuclear cells accumulating at the 
interface between PBS and Histopaque were collected and transferred to another tube; 
10 mL of PBS were added, and the tube was centrifuged with 250 grams at 20 °C for 10 
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min. The pellet was resuspended in 1 mL of culture medium (DMEM + 10% FBS). The 
trypan blue method was used to assess cell viability and counting was done in a 
Neubauer chamber. After that, the cells were plated on thin slides (diameter = 10 mm) 
of bone (CTR), and samples of considered compounds were placed in 24-well culture 
plates and incubated at 37 °C in 5% CO2 for 90 minutes. 
Twenty-four hours later, the non-adherent cells were washed off, to rid the culture of 
contaminating lymphocytes, so that adherent monocytes alone were used for culture, 
and the medium was replaced with osteoclast differentiation medium (DMEM + 10% 
FBS + 10-7 M PTH, 25 ng mL-1 M-CSF, 3 ng mL-1 RANKL). The cells were cultivated 
for up to 21 days. 
After 1 week, cells cultured on the CTR bone slides were TRAP-stained exactly 
according to the manufacturer’s instructions (Sigma, Buchs, Switzerland). The positive 
cells stained red in different intensities. To measure the resorbed area in the pit-assay, 
bone slides with cultured cells were washed with PBS at the end of the experimental 
time, incubated in 5% sodium hypochlorite for 10 min, washed twice with water, and 
stained with 0.1% toluidine blue, as a result of which the pits turned blue to purple. 
Phalloidin staining and WST-1 test were performed on the experimental samples. 
Samples of each material were processed for scanning electron microscopy 
investigation at the end of the experiment. Osteoblasts grown on the materials were 
fixed in 2.5% glutaraldehyde, in pH 7.4 phosphate buffer 0.01 M for 1 hour and 
dehydrated in a graded ethanol series. After a passage in hexamethyldisilazane, the 
samples were air dried and sputter-coated with Pd/Pt prior to examination with a Philips 
XL-20 scanning electron microscope operating at 15 kV. 
Statistical evaluation of data was performed using the software package SPSS/PC+ 
StatisticsTM 10.1 (SPSS Inc., Chicago, IL). The experiment was repeated three times 
and the results presented are the mean of the triplicate values. Data are reported as mean 
± SD at a significance level of P < 0.05. After having verified normal distribution and 
homogeneity of variance, a one-way ANOVA was done for comparison between 
groups. Finally, Scheffé’s post hoc multiple comparison tests were performed to detect 
significant differences between groups [132]. 
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5. Results and Discussion 
 
5.1 Strontium-Substituted Hydroxyapatite 
 
Among the bivalent cations that can replace calcium in CaHA, strontium has attracted 
remarkable interest for its possible biological role. Strontium is present in the mineral 
phase of bone, especially at the regions of high metabolic turn-over [133], and its 
beneficial effect in the treatment of osteoporosis is well known [134]. In vitro, strontium 
increases the number of osteoblasts and decreases the number and the activity of 
osteoclasts [134, 135], whereas strontium administration reduces bone resorption and 
stimulate bone formation [136 - 138]. Strontium can replace calcium in the HA 
structure in the whole range of composition. The solid solutions, which have been 
obtained by hydrothermal methods or by treatment at high temperatures, display a linear 
variation of the lattice parameters with composition, whereas different data are reported 
on the preferential substitution site of Sr for Ca in CaHA [139]. A better understanding 
of the interaction of Sr with hydroxyapatite structure could provide useful information 
also for clarifying the biological role of Sr on the process of biomineralization of bone 
and related pathologies. With this aim, we have carried out a chemical, morphological 
and structural analysis of calcium-strontium-hydroxyapatite solid solutions prepared by 
direct synthesis in aqueous medium. 
The X-ray diffraction patterns of the solid products synthesized with different 
Sr/(Ca+Sr) molar ratios are shown in Figure 16. All the patterns indicate the presence of 
hydroxyapatite as a unique crystalline phase. The patterns of the samples corresponding 
to CaHA (Sr0) and to SrHA (Sr100) display well-defined and sharp peaks in agreement 
with a high degree of crystallinity of the two end members. On the other hand, the 
patterns of the samples containing both Ca and Sr generally exhibit broader diffraction 
peaks, in agreement with a reduced degree of crystallinity of the mixed Ca-Sr-HA. The 
broadening is more evident for the samples with smaller Sr content, suggesting a greater 
difficulty for CaHA to host the greater strontium ion than for SrHA to host the smaller 
calcium ion (Ca2+ ionic radius = 0.100 nm; Sr2+ ionic radius = 0.118 nm).  
Strontium relative amount in the solid products, 
Sr, evaluated through atomic 
absorption spectrometry is reported in Table 2 as a function of strontium content in 
solution. The values of 
Sr increase on increasing Sr/(Ca+Sr) in the starting solution, in 
agreement with a quantitative incorporation of strontium in the solid phase. The ratio 
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between the two cations in the solid phase is very close to that in the synthesis solution. 
Just the samples obtained from solutions with Sr/(Ca + Sr) molar ratios smaller than 0.5 
exhibit 
Sr lower than Sr/(Ca + Sr) indicating a slight preference of CaHA for Ca2+ ions. 
The isomorphous substitution does not significantly affect the stoichiometry of HA as 
it can be deduced from the (Ca+Sr)/P molar ratio which assumes a mean value of 1.68 ± 
0.03, very close to the stoichiometric value of 1.67, independently from the Ca and Sr 
content. 
The FT-IR spectra of the solid solutions show a decrease of the relative intensity of 
the absorption bands due to OH- stretching and libration modes respectively, on 
increasing 
Sr (Figure 17). 
 
 
 
 
Fig. 16 - Powder X-ray diffraction patterns of: Sr0 (azure line); Sr30 (pink line); Sr50 (red line); 
Sr70 (blue line); Sr100 (green line). 
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Furthermore, the OH- stretching band, which is at 3572 cm-1 in Ca-HA, progressively 
shifts to higher wave numbers on increasing strontium content, up to 3590 cm-1 for Sr-
HA, whereas the OH- libration band shifts from 630 cm-1 to 537 cm-1, in agreement with 
the results previously reported for Ca-HA and Sr-HA. The infrared absorption bands 
due to phosphate groups shift to lower wave numbers on increasing strontium relative 
content. Figure 18 shows how the bands due to the symmetric stretching (1) and 
bending (4) modes of phosphate groups move respectively 1 from 962 (Ca-HA) to 947 
cm-1 (Sr-HA) and 4 from 603 (Ca-HA) to 592 cm-1 (Sr-HA). Both shifts proceed in a 
linear way as a function of 
Sr.  
The approximately linear decrease in frequencies of the internal phosphate modes on 
going from CaHA to SrHA, to BaHA, was interpreted by Fowler [140] as indicating 
that the predominant factor causing shifts in the internal PO4 frequencies to lower 
energies is decreased anion-anion repulsion concomitant with increased anion-anion 
separation on increasing cation radius. In agreement, the shift of the infrared absorption 
bands due to phosphate groups with increasing 
Sr can be ascribed to the increasing 
mean dimensions of the cation. 
The results of TEM investigation indicate that the morphology of the apatitic crystals 
is affected by the chemical composition. 
 
 
Table 2 – Strontium relative amount in the solid products, evaluated through atomic 
absorption spectrometry reported as a function of Strontium content in solution. 
 
Sample 
Sr/(Ca + Sr) 
sample molar 
ratio in the 
solution 
Sr/(Ca + Sr) 
sample molar 
ratio in the solid 
product 
Sr0 0 0 
Sr3 0.03 0.01 
Sr5 0.05 0.03 
Sr10 0.10 0.07 
Sr20 0.20 0.18 
Sr30 0.30 0.27 
Sr50 0.50 0.49 
Sr70 0.70 0.71 
Sr90 0.90 0.93 
Sr100 1.00 1.00 
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Figure 19 compares the TEM micrograph of Ca-HA crystals with those of apatitic 
crystals with different 
Sr. Ca-HA is constituted of plate shaped crystals, with mean 
dimensions up to about 200  40 nm (Figure 19(a)). Ca-Sr-HA nanocrystals at small Sr 
content (0< 
Sr 0.5) display more perturbed shapes and ill-defined edges (Figure 
19(b)), in agreement with the lower degree of crystallinity put into evidence by the 
broadening of the X-ray diffraction peaks. At relatively greater Sr content (
Sr  0.7), 
the crystals dimensions increase on increasing 
Sr (Figure 19(c)). Sr-HA crystals display 
mean dimensions of about 500  100 nm and very well defined shape elongated in a 
direction parallel to the crystallographic c-axis (Figure 19(d)). 
The values of specific surface area measured on HA samples applying the BET 
method are reported in Table 3. In accordance with TEM results, the surface area, which 
assumes a value of 60 m2/g for CaHA, increases slightly on increasing 
Sr up to about 
0.3, and then decreases for samples containing 
Sr > 0.5, reaching the minimum value of 
26 m2/g for SrHA. 
 
         
 
Fig. 17 - FT-IR adsorption spectra of Sr0 (blue line) and Sr100 (red line), the arrows on the 
left stand for phosphate stretching (4), those on the right for the phosphate bending (1). 
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Line profile analysis has been applied in order to investigate the line broadening 
increase and the peaks shifts observed in the XRD patterns of the samples (Figure 20). 
A qualitative estimation of the size of coherently scattering domain (i.e. the crystallite 
size) as derived from the Scherrer equation, on the hypothesis of negligible microstrain, 
is reported in Table 4. 
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Fig. 18 - Shifts of the infrared absorption bands due to phosphate groups stretching (red 
squares) and bending (green squares) plotted as a function of 
Sr. 
 
 
002 is related to the mean crystallite size along the c-axis whereas 310 refers to the 
mean crystal size along a direction perpendicular to it. At strontium content smaller than 
cm -1 
cm -1 
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50% the crystallite sizes decrease as 
Sr increases. However, both 002 and 310 decrease, 
but the contraction appears to be slightly greater along the c-axis direction. As a matter 
of fact, the observed maximum contraction is of about 75% along the 002 direction, and 
of about 60% along the 310 direction. 
 
 
  (a)   (b) 
  (c)   (d) 
 
Fig. 19 - TEM micrographs of (a) Sr0; (b) Sr20; (c) Sr70; (d) Sr100 crystals. Scale bars = 200 nm. 
 
 
Table 3 – Specific surface area measured on hydroxyapatite samples 
applying the BET method. 
 
Samples Surface Area 
(m2/g) 
Sr0 60 
Sr10 60 
Sr20 66 
Sr30 72 
Sr50 66 
Sr70 44 
Sr90 40 
Sr100 26 
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For higher strontium contents, crystallite sizes progressively increase up to reach the 
maximum values in Sr-HA. 
In order to acquire further information on the modifications of hydroxyapatite 
structure induced by strontium substitution for calcium, the samples were submitted to 
whole pattern fitting minimization procedure. The results of the structural parameters 
refinements are reported in Table 5 for three selected samples. 
Table 6 shows the relative data concerning metal cation distribution. The value of the 
overall strontium content of these samples, as obtained from the refinements without 
any constrain, is close to the results of the chemical analysis with the exception of 
sample Sr50 which exhibits a slightly lower value. 
The comparisons between the observed and calculated profiles of Sr5, Sr10, Sr50 and 
Sr100 are displayed in Figure 20. 
The structural refinements reveal that strontium atoms occupy both the M(1) and M(2) 
sites of the apatitic structure. 
As regards the debated topic of strontium distribution, the results of Table 6 show that 
at very low strontium content the occupancy of M(1) is higher than the statistical one, 
but when the strontium content increases the situation is reversed. 
This result explains both the data of Kikuchi et al. that in hydrothermally grown single 
crystal containing 1.9 Sr atom % found a preferential substitution of Sr for Ca at M(1) 
site, and the data of other authors that in samples containing > 10 Sr atom % found a 
preferential Sr occupancy of M(2) sites [141]. 
 
Table 4 – Coherent lengths (hkl) of the perfect crystalline domains in the 
direction normal to 002 and to 310 planes calculated using the Scherrer method. 
 
Samples  002 (Å)  310 (Å) 
Sr0 469 (5) 224 (6) 
Sr3 408 (1) 222 (4) 
Sr5 396 (1) 217 (4) 
S r10 385 (5) 153 (6) 
Sr20 212 (7) 92 (7) 
Sr30 168 (4) 86 (8) 
Sr50 113 (4) 93 (5) 
Sr70 293 (3) 190 (3) 
Sr90 391 (6) 230 (2) 
Sr100 490 (5) 305 (3) 
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The strontium replacement of the calcium at M(2) sites allows a better 
accommodation of the bigger strontium atoms because in this position metals atoms 
form “staggered” equilateral triangles centered on the apatitic channel, whereas in the 
M(1) site metals are strictly aligned in columns parallel to the c axis. At very low 
strontium content it is present only in a limited number of unit cells, and it is in M(1) 
site only in a fraction of them. As an example, in Sr5 which contains 3.5 Sr atom %, 
strontium is present only in one cell out of three, and it is in M(1) only in one cell out of 
five. 
This suggests that the driving force in the distribution process is the optimization of 
metal-oxygen interaction: M(1) site allows to accommodate a larger cation because of 
the longer M(1)-O mean distances. 
However, when the number of the bigger ions increases, the repulsion between atoms 
in M(1) position would cause an enlargement of the c-axis that is partially restrained by 
accommodating Sr atoms in site M(2).  
 
 
 
 
Fig. 20 - Comparison between (i) the observed, (ii) calculated and (iii) difference 
powder diffraction patterns of (a) Sr5, (b) Sr10, (c) Sr50 and (d) Sr100 samples. The 
dotted line represents the calculated background. 
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Although a preferential distribution for the cation is detected, the cell parameters plot 
exhibits a good linearity as a function of composition (Figure 21), likely because of the 
moderate difference from the statistic distribution in the two sites. In the case of mixed 
calcium-lead hydroxyapatite solid solutions the larger amount of preferential 
distribution provokes a significant discontinuity in the cell parameters variation [54]. 
 
Table 5 - Cell parameters, fractional atomic coordinates (nm), occupancy factors, atomic 
displacement parameters for mixed Ca-Sr-HA (e.s.d. in parentheses). 
 
 
x Y z O.F. 
Biso 
[Å2] 
Sr5 a=0.94437(3) c=0.68918(2) Rp=4.8 Rwp=6.2 
 
M(1) 0.3333 0.6667 0.0018(6) 0.016(1)* 2.81 
M(2) 0.2442(5) 0.9929(6) 0.2500 0.013(1)* 2.81 
P 0.4000 0.3690 0.2500 0.5000 2.0 
O(1) 0.3318(4) 0.4846(5) 0.2500 0.5000 3.0 
O(2) 0.5857(5) 0.4676(7) 0.2500 0.5000 3.0 
O(3) 0.3411(5) 0.2617(6) 0.070(2) 1.0000 3.0 
O(H) 0.0000 0.0000 0.1897(8) 0.1667 3.0 
Sr10 a=0.94511(3) c=0.69017(2) Rp=3.6 Rwp=4.7 
 
M(1) 0.3333 0.6667 0.0029(5) 0.016(1)* 2.91 
M(2) 0.2430(6) 0.9929(5) 0.2500 0.034(1)* 2.91 
P 0.4000 0.3690 0.2500 0.5000 2.0 
O(1) 0.3307(5) 0.4835(7) 0.2500 0.5000 3.0 
O(2) 0.5855(7) 0.4685(5) 0.2500 0.5000 3.0 
O(3) 0.3418(6) 0.2617(6) 0.070(1) 1.0000 3.0 
O(H) 0.0000 0.0000 0.186(1) 0.1667 3.0 
Sr50 a=0.96300(4) c=0.71026(2) Rp=2.6 Rwp=3.4  
M(1) 0.3333 0.6667 -0.0028(5) 0.122(2) * 2.86 
M(2) 0.2415(7) 0.9879(7) 0.2500 0.256(3) * 2.86 
P 0.4000 0.3690 0.2500 0.5000 2.0 
O(1) 0.3352(7) 0.4842(6) 0.2500 0.5000 3.0 
O(2) 0.5822(6) 0.4637(6) 0.2500 0.5000 3.0 
O(3) 0.3411(6) 0.2638(6) 0.075(1) 1.0000 3.0 
O(H) 0.0000 0.0000 0.1890(9) 0.1667 3.0 
 
 * Relative to strontium atoms 
The pattern R-factor Rp is defined as Rp = 100{Σ |Yoi – Yci| / Σ Yoi} 
The weighted pattern R-factor Rwp is defined as Rwp = 100{Σwi(Yoi – Yci)2 / Σwi(Yoi)2}1/2. 
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The refinement of the SrHA sample was performed only with the idea to compare and 
validate the procedure. The single crystal data perfectly fitted the experimental ones and 
gave non-crystallographic parameters very similar to those find for the other samples. 
The atomic coordinates of the Ca-Sr-HA solid solutions are very similar and no 
significant variation in the atom positions is appreciated [142]. 
Cell proliferation and markers of osteoblast synthetic activity were tested to evaluate 
osteoblasts behavior when cultured on Sr-HA at different Sr contents. The tests were 
carried out on samples Sr0%, Sr3%, Sr5% and Sr10%, which contain strontium amount 
in a biologically relevant range (0, 1, 3, 7% respectively). 
 
 
Table 6 – Strontium distribution over metal sites. 
 
Sample Sr/cell 
Refinement 
distribution 
(A) 
Statistic 
distribution  
(B) 
(A-B / B) 
  
M(1) M(2) M(1) M(2) M(1) M(2) 
Sr5 0.35 0.20 0.15 0.14 0.21 +0.41 -0.27 
Sr10 0.59 0.19 0.41 0.24 0.35 -0.21 +0.15 
Sr50 4.54 1.46 3.07 1.82 2.72 -0.20 +0.13 
 
 
 
 
6,0
6,5
7,0
7,5
8,0
8,5
9,0
9,5
10,0
0 20 40 60 80 100
 

Sr 
 
Fig. 21 – Plot of the hydroxyapatite cell parameters a (pink squares) and c (azure 
squares) as a function of Sr amount (
Sr). 
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Osteoblast proliferation increases up to 14 days, and then it decreases. No significant 
difference was found among all groups at 7 and 21 days, whereas in the other 
experimental times osteoblasts cultured on Sr10 showed significantly greater 
proliferation when compared to Sr0. In brief, cells grow on Sr0 reference samples as 
well as on Sr3 and Sr5, whereas on Sr10 they reach statistically higher values (Figure 
22(a)).  
ALP activity is generally higher in Sr5 and Sr10 groups than in Sr3 and Sr0 groups.  
In particular, the highest value of ALP activity was recorded for Sr10 at 14 days, 
whereas it decreases at 21 days (Figure 22(b)). The production of CICP was not 
influenced at 3 days, whereas at 7, 14, and 21 days CICP level was significantly higher 
in Sr5 and Sr10 groups when compared to Sr0 and Sr3 (Figure 22(c)). No differences 
were found for OC at 3 and 7 days among groups, but at 14 and 21 days OC was 
significantly higher in Sr5 and Sr10 in comparison with Sr0 and Sr3 groups (Figure 
22(d)). These results are consistent with the different properties of the examined 
parameters. 
ALP is an early expression of a more differentiated state, osteoblast phenotype and 
differentiation, with the production of CICP, while OC is late marker of osteoblast 
differentiation. Furthermore, they indicate that the presence of strontium in the samples 
promotes osteoblast differentiation and activity. 
Strontium also affects osteoclast culture, as shown by the significant reduction of cell 
proliferation on Sr3, Sr5, and Sr10 samples in comparison with Sr0 (Figure 23).  
SEM images show cells with the typical features of functional osteoclasts. Osteoclasts 
grown on Sr0 are large, flat cells with a ruffled border (characteristic morphology of 
osteoclasts grown in vitro), as shown in Figure 23(a). 
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Fig. 22 - Proliferation, differentiation, and synthetic activity of MG63 after 3, 7, 14, and 21 days of 
culture on samples of Sr0, Sr3, Sr5, and Sr10. Mean, n 5 6 triplicates (*p < 0.05; **p < 0.005; ***p < 
0.0005). (a) WST1: 3 and 14 days, pp*Sr10 versus Sr0; 7 and 21 days, n.s. (b) ALP: 3 days, *Sr3, Sr10 
versus Sr0; 7 days, **Sr5, Sr10 versus Sr0, Sr3; 14 days, **Sr5 versus Sr0, Sr3; ***Sr10 versus Sr0, 
Sr3; 21 days, *Sr5 versus Sr0, Sr3, Sr10. (c) CICP: 3 days, n.s.; 7 days, *Sr5, Sr10 versus Sr0, Sr3; 14 
days, *Sr5 versus Sr0, Sr3 and **Sr10 versus Sr0, Sr3; 21 days, **Sr5, Sr10 versus Sr0, Sr3. (d) OC: 3 
and 7 days, n.s.; 14 days, ** Sr10 versus Sr0, Sr3, Sr5; 21 days, ** Sr5, Sr10 versus Sr0, Sr3. 
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These cells are polymorphic, suggesting active motility, and have some vesicles 
associated with the ruffled border. Osteoclast grown on Sr containing samples generally 
show less filopodia and develop less ruffled borders, suggesting an inhibitory effect of 
Sr on the bone-resorbing activity, as it can be observed in Figures 23(b) and 23(c) for 
Sr5 and Sr10, respectively. 
 
 
 
 
 
 
Fig. 23 – SEM images of osteoclasts growth on Sr0 (a), Sr5 (b) and Sr10 (c) substrates 
(scale bars = 10 µm). 
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Previous results showed that Sr salts enhance bone cell replication and bone formation 
in vitro, with a dose dependent effect, both when directly administrated in cell culture, 
and when associated to calcium-phosphate scaffolds. Moreover the significant effect of 
Sr on osteoclast culture is in agreement with its inhibiting role on bone resorption 
through reduction of osteoclast activity and viability [112]. 
 
 
 
5.2 Pulsed Laser Deposited Sr-Hydroxyapatite 
 
 
Sr-hydroxyapatite, in the same range of strontium content, were used to coat titanium 
substrates by means of Pulsed Laser Deposition in order to improve the bioactivity of 
titanium. 
The XRD patterns of the PLD thin films are shown in Figure 24. All the patterns are 
consistent with the presence of HA as the sole crystalline phase. In agreement with the 
data obtained from the powders, patterns in Figure 24 show a slight broadening of the 
diffraction peaks, consistent with a shortening of the perfect crystalline domains, where 
strontium concentration was increased. However, the resolution of the patterns was 
quite good, indicating a relatively high degree of crystallinity of the coatings, at 
variance with what was recently reported on plasma-sprayed strontium-substituted HA.  
SEM images in Figure 25 show that the thin films displayed granular surfaces, with 
grains smaller than 1	m on average. The presence of Sr2+ had no significant effect on 
the morphology of the coatings, which remained very similar to those previously 
obtained from apatites of different compositions.  
Nevertheless, EDS investigation results clearly indicated the presence of increasing 
amounts of strontium in the coatings deposited from Sr1 (Sr content: 0.5%), Sr5 (Sr 
content: 3%) and Sr10 (Sr content: 7%), as can be seen in Figure 26.  
This confirmed that PLD was able to produce thin films with a composition close to 
that of the initial powders. Furthermore, the EDS maps in Figure 26 are consistent with 
a homogeneous strontium distribution on the surface of the thin films. The presence of 
strontium significantly improved osteoblast adhesion in early culture phases. In fact, 
cell adhesion increased with increasing strontium content in the coating, as illustrated in 
Figure 27(a–d).  
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Furthermore, strontium influenced cell proliferation and viability (WST-1 test). 
Significant differences were found at all experimental times (Figure 28(a)). In 
particular, values recorded for TiSr5 and TiSr10 were significantly higher than those in 
other groups, and those obtained for TiSr1 were also significantly higher as compared 
with TiHA both after 14 days (P < 0.001) and 21 days (P < 0.0001). 
Osteoblast activity and differentiation were tested through the analysis of selected 
markers, namely ALP, OC and CICP, after 7, 14 and 21 days of culture. The results 
indicated that all markers of osteoblast activation and differentiation were improved in 
proportion to the concentration of strontium in the coating. 
 
 
 
 
Fig. 24 - Thin film XRD patterns of the coatings deposited from Sr0 (the first on 
the bottom), Sr5 (in the middle) and Sr10 (on the top) samples on Ti substrates. 
Asterisks indicate the reflections due to Ti. 
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Fig. 25 - SEM micrographs of thin films deposited from (a) Sr0 and (b) Sr10 samples. Scale bars = 
1	m. 
 
 
 
 
 
Fig. 26 - EDS maps recorded from the coatings: (a) TiSr1; (b) TiSr5; (c) TiSr10. Blue: Ca; red: Sr. 
 
 
ALP showed no differences among the groups after 7 days, but both the TiSr5 (P < 
0.005 and 0.05) and TiSr10 (P < 0.0001) groups revealed significantly high values of 
ALP activity after 14 and 21 days (Figure 28(b)). 
A similar trend was observed for osteocalcin production (Figure 28(c)), which 
showed significant increases in the TiSr5 and TiSr10 groups as compared with TiHA. In 
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this case, the highest level of OC production was reached after 21 days of culture, 
whereas the highest values of ALP activity were recorded after 14 days. This is in 
agreement with earlier reports of an increased expression of ALP as compared with OC 
production during osteoblast differentiation. Also, the production of CICP, as one of the 
major components forming the extracellular matrix, usually occurred later than ALP 
during differentiation. Accordingly, all the samples showed the highest values of CICP 
production after 21 days, with TiSr10 displaying a value significantly higher than those 
recorded in the other samples (Figure 28(d)).  
SEM analyses were performed to evaluate the morphology of cells grown on the 
different materials after 21 days of culture. Osteoblast cell morphologies on TiHA, and 
on the strontium-containing coatings are shown in Figures 29(a–c). 
 
 
 
 
Fig. 27 - Phalloidin staining and percentage of osteoblast adhesion to biomaterial surfaces of culture 
(percent of examined area) 1 hour after seeding on (a) TiHA, (42 ± 4%); (b) TiSr1, (48 ± 8%); (c) 
TiSr5, (58 ± 5%); and (d) TiSr10, (71 ± 13%). TiSr5, TiSr10 vs. TiHA (P < 0.05). Bars = 50 	m. 
 
 
The osteoblasts were observed to attach and spread on the various coatings. On TiHA 
substrates (Figure 29(a)), most of the cells exhibited their phenotypic morphology: the 
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osteoblasts were flattened, had polygonal configuration and dorsal ruffles, and were 
well attached to the substrate by cellular extension.  
Cells grown on strontium-doped HA coatings, however, appeared much more 
flattened and better spread across the surface. The positive effect of strontium on 
osteoblast spreading and proliferation is evident even at the smallest concentration of 
strontium on the coating. 
However, the expressions of the differentiation markers on TiSr1 sample (0.5 at.% Sr) 
were never statistically greater than those recorded on TiHA. 
 
 
 
 
 
Fig. 28 - Osteoblast proliferation and activity after 7, 14 and 21 days of culture on biomaterials. 
Mean, n = 6 triplicates (*P < 0.05; **P < 0.005; ***P < 0.0005): (a) WST1. 7 days: **TiSr5 vs. 
TiHA, ***TiSr10 vs. TiHA, TiSr1; 14 days: **TiSr1, TiSr5 vs. TiHA, ***TiSr10 vs. TiHA; 21 days: 
***TiSr1 vs. TiHA, **TiSr5 vs. TiHA. (b) ALP. 7 days: NS; 14 days: **TiSr5 vs. TiHA; **TiSr10 
vs. TiSr1, ***TiSr10 vs. TiHA; 21 days: *TiSr5 vs. TiHA, **TiSr10 vs. TiHA, TiSr1. (c) OC. 7 days: 
*TiSr5 vs. TiHA, **TiSr10 vs.TiHA; 14 days: **TiSr10 vs. TiHA, TiSr1, TiSr5; 21 days: *TiSr5 vs. 
TiHA, **TiSr10 vs. TiHA, TiSr1. (d) CICP. 7 days: *TiSr10 vs. TiHA, TiSr1; 14 days: n.s.; 21 
days*TiSr5 vs. TiHA, TiSr1, *TiSr10 vs. TiSr5, ***TiSr10 vs. TiHA, TiSr1. 
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At variance, the values of ALP, OC and CICP on TiSr5 (3 at.% Sr) and TiSr10 (7 
at.% Sr) were significantly greater than those recorded on TiHA for most of the 
experimental times. At 21 days the highest expressions of the differentiation markers 
were obtained on TiSr10, with values of ALP, OC and CIPC significantly greater than 
those obtained for TiHA and TiSr1. A significant enhancement of osteoblast response 
has been recently reported also for silicon-substituted HA coatings deposited by 
magnetron co-sputtering. High cell growth, well-organized cytoskeletal architecture and 
enhanced osteoblast biomineralisation observed on Si-HA indicated that Si promotes 
osteoblast metabolism. The cellular actions of strontium have not been fully identified, 
although several mechanisms of action, including activation of the calcium-sensing 
receptor in some cell types, have been postulated.  
However, it is evident that Sr inhibits bone resorption and promotes bone formation, 
and it acts both on osteoblast and osteoclast. 
 
 
 
 
Fig. 29 - SEM micrographs of osteoblasts after 21 days of culture on (a) TiHA, (b) TiSr5 and (c) 
TiSr10. Scale bars = 50 	m. 
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Accordingly, the OPG/TRANCE ratio produced by osteoblasts cultured up to 21 days 
on tested biomaterials showed significantly higher values in TiSr5 (1.41 ± 0.03, P < 
0.0001) and TiSr10 (1.24 ± 0.04, P < 0.05) as compared with TiSr1 (1.14 ± 0.05) and 
TiHA (1.19 ± 0.03), as shown in Figure 30.  
OPG is a member of the TNF receptor family expressed by osteoblasts. It is a 
regulator of bone metabolism and has been shown to act as a potent inhibitor of 
osteoclast differentiation and activation. Its role is linked to Trance, which induces 
osteoclastogenesis and osteoclast activation. Thus, the increased values of the 
OPG/Trance ratio found for the TiSr5 and TiSr10 coatings indicated that strontium 
concentrations greater than 3 at. % inhibit osteoclast production and differentiation. 
Accordingly, the results of osteoclast proliferation 21 days after seeding on biomaterials 
indicated a significant reduction in cell numbers (TiSr5, TiSr10 vs. TiHA, P < 0.05) in 
correlation with the Sr increase in the HA coatings, as shown also by the images of 
fluorescent staining reported in Figures 31(a–d). 
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Fig. 30 - Evaluation of osteoprotegerin and Trance production by cells cultured for 21 days 
on tested biomaterials. 
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Fig. 31 - Phalloidin staining and proliferation (WST1 test) of osteoclast culture 21 days after 
seeding on (a) TiHA (3.285 ± 0.021); (b) TiSr1 (3.252 ± 0.047); (c) TiSr5 (3.211 ± 0.008*); and 
(d) TiSr10 (3.193 ± 0.019*). *TiSr5, TiSr10 vs. TiHA (P < 0.05). Scale bars = 50 	m. 
 
 
 
5.3 Alendronate-Hydroxyapatite Nanocrystals 
 
 
In-vitro tests demonstrated that alendronate is able to promote osteoblast activation 
and extra-cellular matrix mineralization processes, and to inhibit osteoclast proliferation 
even if incorporated in the composite nanocrystals. On the basis of these promising 
results, MAPLE technique was applied to deposit thin films of alendronate-HA 
nanocrystals on Ti substrates. MAPLE to the difference of PLD, in fact, is expected to 
avoid possible damage of alendronate. Sets of thin structures such as simple HA, HA 
doped with 3% alendronate and HA doped with 7% alendronate, were deposited by 
MAPLE on chemically etched Ti substrates.  
The X-ray analysis carried of the thin films obtained by MAPLE technique reveal that 
the degree of crystallinity of the coatings deposited onto Ti substrates appears rather 
low (Figure 32). However, the pattern clearly exhibits the peaks characteristic to HA, 
besides to those characteristic to Ti around 35° of 2. 
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The results of the structural refinements carried out on the composite nanocrystals 
were interpreted as suggesting that alendronate interacts with calcium ions through a 
bidentate chelation of deprotonated oxygen atoms of the bisphosphonate anion without 
greatly affecting the crystal structure of HA [117].  
SEM images of the coatings (Figure 33 (a, b)) show that the deposits consist of grains 
smaller and less defined with respect to those usually obtained through PLD.  
After evaluation of the synthesized nanostructures, the optimal deposition conditions 
were established as described in Table 7.  
These data are of high biological relevance since they indicate that it is possible to use 
MAPLE to synthesize a coating that combines the bioactivity of HA with the local 
availability of alendronate. 
 
 
 
 
 
Fig. 32 - The powder X-ray diffraction patterns of HA nanocrystals containing 7 % wt of 
alendronate (black line); and MAPLE coating synthesized from the same alendronate-doped HA 
(pink line). 
 
 
 
Table 7 - Deposition conditions of Al-HA coatings obtained by MAPLE. 
 
 
Sample 
 
Target Substrate 
 
Substrate 
T(oC) 
 
Pressure 
( torr) 
Distance  
target-substrate 
(cm) 
 
Fluence 
(J/cm2) 
 
No. of 
pulses 
HA HA Ti 30 10-1 4 0.75 20.000 
HA-AL7 HA-AL7 Ti 30 10-1 4 0.75 20.000 
HA-AL28 HA-AL28 Ti 30 10-1 4 0.75 20.000 
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The results of in vitro tests indicated that alendronate promotes osteoblast 
proliferation and viability. 
At 1, 7 and 14 days osteoblast proliferation was assessed by WST1 test (Figure 34). 
Recorded values showed that osteoblasts grew regularly on all substrates when 
compared to control (cells on culture plates without biomaterials), but at all 
experimental times HA-AL7 and HA-AL28 groups were significantly higher than HA 
(1, 7 and 14 days) and Ti (1 and 7 days) groups. 
On culture supernatant the following parameters were evaluated at 7 and 14 days: 
ALP and CICP as early differentiation markers, OC as later mineralization marker, and 
OPG and RANKL as index of bone formation/resorption balance during the last stage of 
differentiation.  
 
 
 
 
 
Fig. 33(a, b) - SEM micrographs of thin films deposited from HA containing 
7 % wt of alendronate at two different enlargements. Scales bar = 2 	m (a) 
and 10 	m (b). 
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The evaluation of ALP activity showed no differences among groups at 7 days, while 
at 14 days Ti group showed significant lower values than other groups (Figure 35(a)). 
The production of CICP was significantly higher in both HA-AL7 and HA-AL28 
when compared to HA (7 and 14 days) and Ti (7 days) (Figure 35(b)). 
The level of OC also at 7 days was significantly higher in both HA-AL7 and HA-
AL28 when compared to HA and Ti groups, even if at 14 days no differences where 
found among groups (Figure 35(c)). 
The results demonstrated that in the presence of alendronate osteoblasts seem to show 
an higher rate of proliferation and earlier differentiation when compared to other 
groups. 
OPG and RANKL have been also implicated in bone metabolism. Specifically, the 
balance of these factors is believed to be key in determining the rate of 
osteoclastogenesis and the net outcome of bone formation/resorption. Alendronate not 
only significantly improves the OPG production (HA-AL28 at 14 days when compared 
to other groups, p < 0.05), but also led to a reduction of RANKL expression (HA-AL7 
and HA-AL28 at 14 days when compared to other groups, p < 0.05). 
The results of OPG/RANKL ratio (Figure 35(d)) were significantly higher in 
alendronate groups both at 7 and 14 days, demonstrating that alendronate influences 
osteoblast metabolism, increasing the release of soluble OPG relative to RANKL and 
favouring a bone-forming (and resorption-inhibiting) event. Therefore, an increased 
OPG/RANKL ratio could favour bone formation and contribute to successful 
osseointegration. 
SEM analyses were performed to evaluate the morphology of cells grown on the 
different materials after 14 days of culture. Figures 36(a–d) show that the osteoblasts 
attach and spread on the various coatings. Most of the cells exhibit their phenotypic 
morphology: the osteoblasts are flattened, display polygonal configuration and dorsal 
ruffles, and are well attached to the substrate by cellular extensions. 
Cells grown on HA coatings, and even more on HA-AL7 and HA-AL28 coatings, 
appear more flattened and better spread across the surface than those on bare Ti. 
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Fig. 34 - Proliferation of MG63 (WST1 tests) after 1, 7 and 14 days of culture on samples of Ti, HA, 
HA-AL7 and HA-AL28. Mean ±sd, n = 3. (* = p<0.05; ** = p<0.005; *** =p<0.0001); 1 day: *HA-
AL7 versus Ti, HA; *HA-AL28 versus HA; 7 days: ***HA versus Ti, HA-AL7, HA-AL28; 14 days: 
*HA versus HA-AL7, HA-AL28. 
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Fig. 35(a-d) - Differentiation and synthetic activity of MG63 after 7 and 14 days of culture on samples of 
Ti, HA, HA-AL7 and HA-AL28. Mean ±sd, n = 3. (* = p<0.05; ** = p<0.005; *** =p<0.0001): 
  (a) ALP. 7 days: ns; 14 days: **HA, HA-AL28 versus Ti; *HA-AL7 versus Ti. 
  (b) OC. 7 days: *HA-AL7 versus HA; *HA-AL28 versus Ti; **HA-AL28 versus HA; 14 days:  ns.  
  (c) CICP. 7 days: ***HA versus Ti, HA-AL7, HA-AL28; 14 days: * HA-AL7, HA-AL28 versus HA. 
  (d) OPG/RANKL ratio. 7 days: *HA-AL7 versus HA; *HA-AL28 versus Ti; **HA-AL28 versus HA; 
        14 days: ***Ti versus HA, HA-AL7, HA-AL28. 
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 (a)  (b) 
 
 (c)  (d) 
 
Fig. 36(a-d) - SEM micrographs of osteoblasts after 14 days of culture on Ti (a), HA (b), HA-AL7 
(c) and HA-AL28(d). 
 
 
 
5.4 Bivalent Ions Modified OCP 
 
 
OCP was synthesized in the presence of increasing amounts of Sr, Mg and Mn ions. 
The first step of this study consisted in the optimization of OCP synthesis aimed to 
obtain separated crystals. The following parameters were considered: the temperature 
(60 or 70°C), the total time used to drop Ca(COO)2  H2O into the phosphates solution, 
that is 1 hour, 40 or 20 minutes, and the speed of mechanical stirring (1 round every 2 
seconds, 2 rounds per second, 5 rounds per second). The results of these optimization 
tests are resumed in the following tables (Tables 8 and 9). It is interesting to mention 
that only at 70 °C, with 2 circles per second and in one hour dropping it is possible to 
obtain separate OCP crystals (Figure 37). 
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Table 8 - Morphology of OCP crystals obtained by varying dropping and stirring speeds at 60°C. 
 
T = 60°C 1 h dropping 40 min dropping 20 min dropping 
1 round / 
2 seconds 
separate crystals + 
spherules 
aggregate crystals aggregate crystals 
2 rounds / 
1 seconds 
spherules spherules spherules+DCPD 
5 rounds / 
1 seconds 
spherules aggregate crystals aggregate crystals 
 
 
Table 9 - Morphology of OCP crystals obtained by varying dropping and stirring speeds at 70°C. 
 
T = 70°C 1 h dropping 40 min dropping 20 min dropping 
1 circle / 
2 seconds 
separate and 
aggregate crystals 
aggregate crystals aggregate crystals 
2 circle / 
1 second 
separate crystals 
separate but 
disordered crystals 
aggregate crystals 
5 circle / 
1 second 
Separate but 
disordered crystals 
spherules spherules 
 
 
 
 
 
 
Fig. 37 - SEM image of separated OCP crystals obtained at 70°C, with 1 hour dropping 
phosphates solution, with a speed of stirring = 2 circles/1 sec (scale bar = 10 	m). 
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5.4.1 Strontium Substitution 
 
Increasing amounts of Sr(COO)2  H2O, covering all the range of percentages, were 
added along with Ca(COO)2  H2O in the reaction solutions.  
The XRPD patterns demonstrated that OCP phase was obtained at 70°C (Figure 39). 
Anyway, the introduction of even small amounts of a different ion deeply affects the 
resulting crystal morphology (Figure 40). Just a little amount of strontium ions 
provokes the aggregation of single crystals (Sr 5%) to form a spherule (Sr 10%), while 
at relatively higher Sr concentration the products consist of disordered aggregates (Sr 
50%). At concentration higher than 80% no precipitate was observed. The crystal 
phases obtained at the different concentrations are reported in Table 10. Quite different 
results, not only in morphology but also in the crystal phases, were observed at 60°C. 
At 60°C OCP precipitates together with DCPD only up to 5% Sr in solution. Then, 
only DCPD precipitation was observed. From 60% to 90% of strontium no CaP 
compound precipitated while at 100% Sr, SrHPO4 was obtained.  
Attention has been focused on those samples constituted only of OCP, that is on the 
products obtained at 70°C.  
As results by the EDS analysis (Figure 41), Sr is present in the OCP powder. The 
results of the powder pattern fitting carried out with the Rietveld method (Figure 42), 
show that the cell parameters increase on passing from OCP to Sr10%-OCP to Sr15%-
OCP, suggesting a partial replacement of Ca with Sr in the OCP structure (Table 11).  
 
5 10 15 20 25 30 35 40 45 50 55
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Fig. 39 - 0% (black line), 10% (brown line), 30% (blue line), 50% (red line) Sr OCP 
substituted XRPD patterns. 
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Table 10 - Crystal phases obtained by OCP synthesis in presence of Sr ions. 
 
%Sr T = 60°C T = 70°C 
3 OCP+DCPD OCP 
5 OCP+DCPD OCP 
10 DCPD OCP 
15 DCPD OCP 
20 DCPD Disordered OCP 
40 DCPD Disordered OCP 
50 DCPD Disordered OCP 
60 No ppt Disordered OCP 
80 No ppt No ppt 
100 SrHPO4 No ppt 
 
 
 (a) 
 
 (b) 
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 (c) 
 
Fig. 40(a-c) - SEM images of Sr 5%, 10% [(a) and (b) respectively, scale bars 
50	m), 50% (c, scale bar 5	m) OCP substituted. 
 
 
Fig. 41 - EDS analysis of OCP with a theoretical 15% Sr. 
 
 
Fig. 42 - Comparison between observed and calculated Sr10% OCP diffractograms. 
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  Table 11 - Cell parameters of OCP and Sr substituted OCP. 
 
PARAMETER OCP OCP-Sr 10% OCP-Sr 15% 
a 19.695(5) 19.716(5) 19.75(1) 
b 9.540(3) 9.558(4) 9.580(7) 
c 6.834(3) 6.846(3) 6.861(4) 
 90,27(3) 90.24(3) 90.35(7) 
 92,57(3) 92.60(3) 92.59(7) 
 108,32(3) 108,30(3) 108.27(9) 
V 1218(1) 1223(1) 1231(1) 
 
 
 
5.4.2 Magnesium Substitution 
 
In the same way, OCP synthesis was performed in the presence of Mg. We chose to 
operate at 60°C or 70°C, 2 rounds per second with 1 hour dropping by adding 
increasing amounts of Mg. At 70°C and at a Mg content up to 15%, OCP is the only 
crystalline phase (Table 12). Then, up to 50% the crystal phase changes and DCPD 
forms. A further increase of Mg concentration completely inhibits precipitation. At 
60°C, OCP is never observed as single phase. At low Mg concentration, the product is a 
mixed phase OCP/DCPD while at higher concentration only crystalline DCPD 
precipitates. 
The XRPD patterns reported in Figure 43, show that OCP is obtained in the presence 
of little amounts of Mg ions in the reaction solution at 70°C, while at higher Mg 
concentration DCPD precipitates. 
A morphological analysis was carried on OCP samples. At 3% of magnesium ions 
OCP crystals are still quite separated (Figure 44(a)). By increasing Mg amount (Figure 
44(b)) the crystals tend to aggregate to form the classical OCP spherules. 15% 
magnesium deeply affects the morphology, so that only disordered crystal aggregates 
are observed (Figure 44(c)).  
The values resulting from accurate structural refinement performed with the Rietveld 
method (Figure 45), reveals that OCP with 10% of magnesium ions exhibits reduced 
lattice parameters (Table 13) according to a smaller unit cell, suggesting a partial 
substitution of the smaller Mg2+ ion to calcium (1.00 Å calcium, 0.72 Å magnesium). 
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OCP obtained in the presence of Mg15% displays lattice parameters not significantly 
different from those of Mg10%. 
 
Table 12 - Crystal phases obtained by OCP synthesis in presence of Mg ions. 
 
%Mg T = 60°C T = 70°C 
3 OCP+DCPD OCP 
5 OCP+DCPD OCP 
10 OCP+DCPD OCP 
15 DCPD OCP 
20 DCPD OCP+DCPD 
40 DCPD DCPD 
50 DCPD DCPD 
60 No ppt No ppt 
80 No ppt No ppt 
100 No ppt No ppt 
 
It can be hypothesized that just a limited amount of Mg can be incorporated into OCP 
structure, before causing a significant disorder of the structure, as indicated by the 
increasing broadening of the diffraction peaks observed at increasing Mg concentration 
(Figure 43). 
 
5 10 15 20 25 30 35 40 45 50 55
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Fig. 43 - XRPD patterns of the powder obtained in presence of 3% (black line), 10% Mg ions (blue 
line) that correspond to OCP, 40% (red line), 50% (green line) of Mg ions that correspond to DCPD. 
5. Results and Discussion 
 
 
 
96
 (a) 
 
 (b) 
 
 (c) 
 
Fig. 44(a-c) - SEM images of the powder obtained in presence of 3% (a), 5% 
(b) and 15% (c) of magnesium ions at 70°C (scale bars = 20	m). 
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 Fig. 45 - Comparison between observed and calculated Mg10% OCP diffractograms. 
 
 
Table 13 - Cell parameters of OCP and Mg substituted OCP. 
 
PARAMETER OCP OCP-Mg 10% OCP-Mg 15% 
a 19.695(5) 19.677(3) 19.684(7) 
b 9.540(3) 9.530(3) 9.533(4) 
c 6.834(3) 6.825(2) 6.829(3) 
 90,27(3) 90.22(2) 90.19(4) 
 92,57(3) 92.57(2) 92.62(4) 
 108,32(3) 108.33(2) 108.33(4) 
V 1218(1) 1213(1) 1215(1) 
 
 
 
5.4.3 Manganese Substitution 
 
The results of Mn ions introduction in OCP synthesis are deeply different from those 
observed in the case of strontium and magnesium. OCP is never obtained. Only at low 
percentages of Mn, a crystalline calcium phosphate phase precipitates (DCPD) both at 
60 and 70°C (Figure 46). 
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With increasing concentrations of Mn, the precipitate is amorphous and then, up to 
100%, no precipitate is obtained but at 60 °C with the 100% of Mn when 
Mn3(PO4)2(H2O)7 precipitates (Table 14). 
 
 
Table 14 - Crystal phases obtained by OCP synthesis in presence of Mn ions. 
 
Mn% T = 60°C T = 70°C 
3 DCPD DCPD 
5 DCPD DCPD 
10 Amorphous phase DCPD 
15 Amorphous phase Amorphous phase 
20 Amorphous phase Amorphous phase 
40 Amorphous phase Amorphous phase 
50 No ppt No ppt 
60 No ppt No ppt 
80 No ppt No ppt 
100 Mn3(PO4)2(H2O)7 No ppt 
 
 
From a morphological point of view DCPD crystals obtained appear deeply similar to 
those of pure DCPD (Figure 47). 
The EDS analysis confirm that the products contain Mn (Figure 48). 
 
5 10 15 20 25 30 35 40 45 50 55
2Theta (°)
 
Fig. 46 - XRPD patterns of the powder obtained in presence of 3% (black line), 5% (pink line) 
and 10% (blue line) of Mn ions. 
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Fig. 47 -  DCPD obtained by OCP synthesis producted in presence of 5% of Mn ions 
(scale bar = 20 	m). 
 
 
 
Fig. 48 - EDS image resulting by the analysis of the sample containing 15% of Mn ions.
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 5.5. Role of Strontium on α-TCP Hydrolysis 
 
In view of the arising interest toward the introduction of Sr ions into the composition 
of calcium phosphate cements, quite often based on the hydrolysis reaction of -TCP 
into HA, we examined the effect of increasing Sr concentration on -TCP hydrolysis. 
The powder X-ray diffraction patterns of the solid products obtained in the absence of 
Sr ions after different periods of -TCP soaking in bidistilled water at 37°C are reported 
in Figure 49, and indicate that a mixed -TCP/HA is present after 18 days of soaking 
while HA is the unique crystalline phase present after 21 days, in agreement with a 
complete hydrolysis of -TCP. 
When the same reaction is carried out at 60°C, 7 days are sufficient to observe the 
complete phase conversion into HA. The presence of strontium in solution inhibits the 
hydrolysis reaction: Figure 50 reports the X-ray diffraction patterns of the products 
obtained after soaking at 60°C for 14 days at different concentrations, and indicates that 
the product obtained in the presence of 5% Sr2+ or more still exhibits diffraction peaks 
characteristic of -TCP. The crystalline phase identified by X-ray diffraction analysis in 
the products of -TCP soaking at different strontium concentrations at 37°C are 
reported in Table 15. The inhibition effect increases on increasing Sr2+ concentration, so 
that just a small amount of -TCP appears hydrolyzed into HA after 21 days of soaking 
in 10% Sr2+ solution at 60°C. 
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Fig. 49 - XRPD patterns of -TCP (black line), a mixed phase -TCP/HA obtained after 18 
days of soaking (azure line) and HA (red line) obtained after 21 days of soaking. 
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The addition of a small amount of DCPD to the starting -TCP powder produces an 
increase in the speed of phase conversion. Table 16 reports the crystalline phases 
identified by X-ray diffraction analysis in the products of -TCP soaking at different 
strontium concentrations at 37 or 60°C in the presence of 5% DCPD. 
 
 
Table 15 – Crystalline phases present in the products of hydrolysis of -TCP 
in water for different periods at 37 or 60°C. 
 
Temperature 37°C 
% Sr2+ 14 days 18 days 21 days 
0 -TCP -TCP/HA HA 
2 -TCP -TCP -TCP 
5 -TCP -TCP -TCP 
10 -TCP -TCP -TCP 
20 -TCP -TCP -TCP 
Temperature 60°C 
% Sr2+ 7 days 14 days 21 days 
0 HA HA HA 
2 -TCP HA HA 
5 -TCP -TCP/HA HA 
10 -TCP -TCP -TCP/HA 
20 -TCP -TCP -TCP 
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Fig. 50 - XRPD patterns of -TCP after 14 days of soaking at 60°C in presence of 0% Sr (black 
line) which gives HA, 5% Sr (red line) which gives a mixed HA/-TCP phase and 10% of 
strontium ions which is still -TCP (green line). 
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At 60°C, HA is the unique crystalline phase after just 24 hours when the hydrolysis is 
carried out in the presence of a strontium concentration up to 5%. After 12 days the 
hydrolysis of -TCP is complete even in the presence of a 20% strontium concentration. 
The lattice parameters of HA obtained from -TCP hydrolysis after 12 days of 
soaking at 60°C are a = 9.45(2) Å, c = 6.87(1) Å, very close to those previously 
reported [54] and do not show any appreciable variation as a function of strontium 
concentration in solution (Table 18). 
The line broadening of the 002 and 310 reflections of HA were used to evaluate the 
coherence lengths of the perfect crystalline domains of the crystals. 
The results are reported in Table 17 and indicate that the coherence lengths of HA 
crystals obtained by -TCP hydrolysis are longer than those previously reported for 
synthetic HA [56]. Furthermore, the values of the coherence lengths display a decrease 
on increasing strontium concentration in solution.  
This could be due to the presence of strontium atoms associated with the solid 
products of the hydrolysis reactions. 
 
 
Table 16 – Products of -TCP in water with 5% DCPD for different periods at 37 or 60°C. 
 
37°C 
% Sr2+ 2 days 3 days 7 days 10 days 14 days 
0 -TCP/ HA HA HA HA HA 
2 -TCP -TCP HA HA HA 
5 -TCP -TCP -TCP -TCP/ HA -TCP/ HA 
10 -TCP -TCP -TCP -TCP -TCP 
20 -TCP -TCP -TCP -TCP -TCP 
60°C 
% Sr2+ 3 hours 6 hours 1 day 3 days 12 days 
0 -TCP/ HA -TCP/ HA HA HA HA 
2 -TCP/ HA -TCP/ HA HA HA HA 
5 -TCP -TCP/ HA HA HA HA 
10 -TCP -TCP -TCP/ HA HA HA 
20 -TCP -TCP -TCP/ HA -TCP /HA HA 
 
 
Indeed EDS analysis put into evidence the presence of strontium in the apatitic 
samples obtained from strontium containing solutions. Figure 51 reports the EDS 
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spectra of samples obtained from solutions in the absence (Figure 51(a)) and in the 
presence of strontium (Figure 51(b) and 51(c)). The amount of strontium in the samples 
increases with respect to calcium on increasing the strontium concentration in  solution 
(Figures 51(b) and 51(c)). 
Moreover, it is possible to monitor the effect of time of strontium incorporation into 
CaP powder. In Figure 52 are reported the EDS analysis of the sample containing 20% 
of strontium ions in the reaction solution. They show how strontium content increases 
from 3 (Figure 52(a)) days to 12 (Figure 52(b)) days of soaking. 
 
 
Table 17 - Average dimensions of crystalline domains in (002) and (310) directions 
for HA samples obtained soaking -TCP in water with 5% DCPD in 12 days at 
60°C. 
 
% Sr2+ τ 002 (Å) τ 310 (Å) 
0 474 (2) 310 (1) 
2 441 (5) 269 (4) 
5 425 (5) 257 (5) 
10 390 (4) 244 (7) 
20 371 (5) 284 (6) 
 
 
Table 18 – Unit cell parameters of HA obtained from α-TCP + DCPD a 60°C with 
different amount of strontium ions inside the solution. 
 
% Sr2+ a parameter (Å) c parameter (Å) 
0 9.45 (2) 6.87 (1) 
2 9.42 (4) 6.87 (1) 
5 9.44 (1) 6.89 (2) 
10 9.48 (4) 6.90 (4) 
20 9.36 (8) 6.88 (5) 
 
5. Results and Discussion 
 
 
 
104
 
Fig. 51(a) - Sample containing 5% Sr2+ after 12 days of soaking in water solution. 
 
 
Fig. 51(b) - Sample containing 10% Sr2+ after 12 days of soaking in water solution. 
 
 
Fig. 51(c) - Sample containing 20% Sr2+after 12 days of soaking in water solution. 
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Figure 43 reports the SEM images of the products obtained after soaking in bidistilled 
water at 60°C for different periods of time. -TCP appears constituted of dense rounded 
blocks with the characteristic morphology of a solid-state product. The presence of 
added DCPD crystals, which display a plate-like morphology, is clearly appreciable in 
the image (Figure 53(a)). After a couple of hours of soaking, small HA crystals appear 
on the -TCP ones (Figure 53(b)). After 6 hours soaking, platelet-like crystals (of HA) 
appear close to the -TCP aggregates (Figure 53(c)). According to the results of X-ray 
diffraction analysis, this material contains both  TCP and HA as crystalline phases. 
After 12 days soaking, only platelet-like crystals of HA with dimensions of few microns 
are present (Figure 53(d)). 
 
 
Fig. 52(a) - Sample containing 20% Sr2+ after 3 days of soaking in water 
solution: no strontium ions are present in the powder. 
 
 
 
Fig. 52(b) - Sample containing 20% Sr2+ after 7 days of soaking in water solution. 
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 (a) 
 (b) 
 (c) 
 (d) 
 
Fig. 53(a-d) - SEM images of -TCP/DCPD powder (a) (scale bar = 10	m), -TCP with 
a few little HA crystals (b) (scale bar = 2	m), -TCP/HA (c) and HA(d) (scale bars = 
10	m) powder after different periods of soaking. 
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On the other hand, when the hydrolysis is carried out in the presence of strontium, the 
shape of the HA crystals obtained after 12 days appears to be different, as it can be 
observed in Figure 54 that reports the SEM micrograph of HA obtained after soaking in 
20% Sr2+ solution. Crystals are rod-like and their length is definitely shorter than 1 µm. 
 
 
 
 
Fig. 54 - SEM image of HA obtained after soaking in 20% Sr2+ solution for 12 days 
(scale bar = 2 µm). 
 
 
 
5.5.1 Hydrolysis in Gelatin Solutions 
 
All samples hydrolysed in presence of gelatin were analyzed by XRPD to identify the 
different crystal phases (Figure 55). The identified crystal phases are reported on the 
basis of the percentage of strontium, gelatin and time of reaction (Table 13). 
At the lower gelatin concentration (0.1%), the hydrolysis of -TCP occurs faster than 
in water (Table 14) and the complete phase conversion into HA is observed after 14 
days. On increasing gelatin concentration in solution to 0.5%, -TCP reaction leads to 
the formation of an OCP/HA mixture in 3 days and HA as unique crystalline phase in 
21 days; whereas at gelatin concentration of 1%, OCP may be obtained as a pure phase 
after just 3 days. 
The presence of strontium in solution inhibits the hydrolysis reaction, so that a 2% 
Sr2+ concentration in 0.1% gelatin is sufficient to avoid any HA formation up to 35 days 
and the same happens for 10% and 20% Sr2+ concentration in 0.5% gelatin. 
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Fig. 55 - XRPD diffractograms of  -TCP soaked in gelatin solution for different time: -TCP (black 
line), -TCP/OCP (red line), OCP/-TCP (blue line), OCP (green line) and OCP/HA (pink line).  
 
Table 13 - Calcium phosphate crystalline phases resulting by  –TCP soaking in 0.1, 0.5, 1% gel 
solution for different periods of time at 37°C. 
 
0.1% gel 
Sr2+ % 7 days 14 days 21 days 28 days 35 days 
0 -TCP HA HA HA HA 
2 -TCP -TCP -TCP -TCP -TCP 
5 -TCP -TCP -TCP -TCP -TCP 
10 -TCP -TCP -TCP -TCP -TCP 
20 -TCP -TCP -TCP -TCP -TCP 
0.5% gel 
 3 days 7 days 14 days 21 days 28 days 
0 OCP/HA OCP>HA HA>OCP HA HA 
2 -TCP OCP>TCP OCP>HA OCP>HA HA 
5 -TCP OCP>TCP OCP>-TCP OCP>-TCP OCP>-TCP 
10 -TCP -TCP -TCP -TCP -TCP 
20 -TCP -TCP -TCP -TCP -TCP 
1% gel 
Sr2+ % 1 days 3 days 7 days 21 days 35 days 
0 –TCP>OCP OCP OCP OCP>HA OCP>HA 
2  -TCP  –TCP>OCP OCP OCP>HA OCP>HA 
5  -TCP  -TCP OCP OCP>HA OCP>HA 
10  -TCP  -TCP  -TCP  –TCP>OCP OCP>HA 
20  -TCP  -TCP  -TCP  -TCP  –TCP>OCP 
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In Figure 56 it is possible to follow the proceeding of hydrolysis reaction. SEM image 
shows  –TCP crystals (a) on which OCP crystals form (b). Then pure OCP crystals are 
visible (c) and after the maximum period of time considered a mixed phase OCP/HA is 
observed (d). 
By means of the QUANTO program it was possible to quantify the percentages of the 
different calcium phosphate crystal phases (Table 15) present in the same sample. As 
shown in Table 15, this program too allow to monitor the conversion of α-TCP to 
hydroxyapatite which involves small portions of the sample at first, and increases with 
time until complete reprecipitation of the most stable calcium phosphate crystal phase. 
 
 
Table 14 - Calcium phosphate crystalline phases resulting by  –TCP soaking in 0.1, 0.5, 1% gel 
solution for different periods of time at 37°C with 5% DCPD. 
 
0.1% gel + 5% DCPD 
Sr2+ % 1 day 7 days 14 days 21 days 35 days 
0 –TCP>>OCP OCP>HA HA HA HA 
2 -TCP OCP>>-TCP HA>>OCP HA HA 
5 -TCP -TCP HA>>OCP 
Poorly cryst. 
HA 
HA 
10 -TCP -TCP  -TCP  –TCP  –TCP 
20 -TCP -TCP  -TCP  –TCP  –TCP 
0.5% gel + 5% DCPD 
Sr2+ % 1 day 3 days 7 days 21 days 28 days 
0 –TCP>>OCP OCP/HA OCP>HA HA HA 
2 -TCP>>OCP OCP>>-TCP OCP HA>OCP HA>OCP 
5 -TCP OCP>-TCP OCP>-TCP HA>OCP HA>OCP 
10 -TCP -TCP -TCP -TCP OCP> HA 
20 -TCP -TCP -TCP -TCP -T CP 
1% gel + 5% DCPD 
Sr2+ % 1 days 5 days 7 days 21 days 35 days 
0 OCP>-TCP OCP OCP OCP>HA OCP>HA 
2 -TCP>OCP OCP OCP OCP>HA OCP>HA 
5  -TCP OCP OCP OCP>HA OCP>HA 
10  –TCP –TCP>OCP OCP>–TCP OCP>HA OCP>HA 
20  -TCP  -TCP  -TCP -TCP -TCP>>OCP 
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 (a)   (b) 
 (c)   (d) 
 
Fig. 56(a-d) - SEM images of the powder in the different steps of  –TCP hydrolysis reaction: starting 
material  –TCP (a) (scale bar = 5 	m), mixed phase  –TCP/OCP (b) (scale bar = 2 	m), OCP single 
crystalline phase (c) (scale bar = 1 	m) and mixed phase OCP/HA (d) (scale bar = 5 	m) obtained 
after the maximum period of soaking. 
 
 
 
 
Table 15 – Percentages of the different calcium phosphates present in the products of hydrolysis. 
 
SAMPLE % α -TCP % OCP % HA 
Sr0% α-TCP in H2O 
1 day 55.8 (7) 44.2 (8)  
21days  6.5 (9) 93.9 (8) 
28 days  19.6 (7) 80.4 (2) 
35 days  17.5 (9) 82.5 (2) 
Sr0% α-TCP + 5% DCPD in H2O 
1 day  75.8 (6) 24.2 (9) 
21 days  63.8 (8) 36.2 (7) 
28 days  51.1 (5) 48.9 (6) 
35 days  22.9 (9) 77.1 (3) 
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Sr2% α-TCP in H2O 
3 days 51.1 (5) 49.9 (7)  
21 days  47.8 (6) 42.2 (6) 
28 days  52.6 (9) 47.4 (8) 
35 days  29.4 (8) 70.6 (4) 
Sr2% α-TCP + 5% DCPD in H2O 
1 day 53.0 (6) 47.0 (9)  
3 days  78.0 (3) 22.0 (9) 
21 days  42.2 (9) 57.8 (9) 
28 days  45.2 (7) 54.8 (5) 
35 days  19.5 (8) 80.5 (3) 
Sr5% α-TCP in H2O 
28 days  47.7 (4) 52.3 (5) 
35 days  28.6 (9) 71.4 (4) 
Sr5% α-TCP + 5% DCPD in H2O 
3 days 48.1 (5) 51.9 (7)  
21 days  67.2 (4) 32.8 (7) 
28 days  51.9 (4) 48.1 (5) 
35 days  45.4 (5) 54.6 (5) 
Sr10% α-TCP in H2O 
35 days  35.7 (6) 64.3 (5) 
Sr10% α-TCP + 5% DCPD in H2O 
21 days  25.8 (7) 74.2 (5) 
28 days  23.3 (6) 76.7 (3) 
35 days  19.9 (5) 80.1 (3) 
 
 
 
5.6 Microspheres 
 
 
Gelatin microspheres were prepared by the so called “thermal gelation technique”: by 
adding a gelatin solution to stirred soy oil, a rapid cooling led to the formation of 
spheres. 
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The morphological analysis carried out on gelatin microspheres by a scanning 
electron microscope shows how these spheres (the cores) are smooth, spherical, with 
diameter dimensions of 10-20 µm (Figure 57). 
The X-ray diffraction analysis reveals an amorphous phase (Figure 58). 
 
 
 
Fig. 57 - SEM image of gelatin microspheres (scale bar = 20	m). 
 
 
 
 
 
Fig. 58 - XRPD pattern of gelatin microspheres. 
 
 
The second step was to coat these microspheres with a thin calcium phosphate layer. 
The parameters of synthesis were optimized so as to obtain homogeneous shells on 
microspheres’ surfaces. In Figure 59 the diffractogram displays that, even with a CaP 
5. Results and Discussion 
 
 
 
113
shell, the resulting phase is still amorphous thus precluding a deeper crystallographic 
analysis. 
From a morphological point of view, the calcium phosphate shell appear thick and 
homogeneous (Figure 60) and no CaP precipitate independently from the gelatin 
microspheres. 
The graph showed below (Figure 61) reports the percentages of gelatin released from 
uncoated (in blue) and coated (in red) microspheres. The values registered for coated 
microspheres are lower than those observed from the calculated released gelatin from 
uncoated microspheres. 78 hours are necessary to make 90% of gelatin released while in 
the same period only 60% of gelatin is released from CaP coated gelatin microspheres. 
This demonstrates the usefulness of CaPs coatings to modulate gelatin release. 
After the optimization of gelatin microspheres synthesis, aspirin was chosen as drug 
model to be loaded and released from gelatin microspheres.  
The XRPD pattern (Figure 62) of aspirin loaded gelatin microspheres is a typical 
amorphous diffractogram as that of unloaded gelatin microspheres was and nothing else 
was expected. 
 
 
 
 
 
Fig. 59 - XRPD pattern of gelatin microspheres coated with a calcium phosphate shell. 
 
From the morphological point of view, aspirin loaded gelatin microspheres appear 
perfectly spherical and smooth even though without regular dimensions (Figure 63). 
After the introduction of calcium phosphate in the reaction medium, the coated 
microspheres were structurally analysed by XRPD. The resulting diffractogram (Figure 
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64) show an amorphous phase again, thus revealing that the calcium phosphate coating 
is amorphous or so thin that X-ray technique is not sufficient to determine it. 
 
 
 
 
Fig. 60 - SEM image of gelatin microspheres coated with CaP (scale bar = 20	m). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 61 - Percentage of released gelatin vs. time from uncoated (blue squares) and coated gelatin 
microspheres (red squares). 
 
Aspirin loaded gelatin microspheres’ coating appears not always homogeneous and 
even if several synthesis were performed it was not possible to reach the good 
homogeneousness obtained in the case of unloaded microspheres, indicating that the 
drug disturbs the deposition on the microspheres surface. The inorganic phase in some 
portions of the coating appear constituted of lamellar crystals (Figure 65). 
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The graphic below (Figure 66) represents the percentages of aspirin released from 
uncoated (green squares) and coated (pink squares) microspheres. 
 
 
 
 
 
Fig. 62 - XRPD pattern of aspirin loaded gelatin microspheres. 
 
 
 
 
      
Fig. 63 - SEM images of uncoated aspirin loaded gelatin mirospheres (scale bar = 5	m). 
 
 
The kinetic of aspirin release from coated microspheres is lower than that obtained 
from uncoated ones only 24 hours are enough to have the 100% of aspirin released for 
uncoated gelatin microspheres whereas the coated gelatin microspheres release the same 
quantity in 48 hours.  
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Although aspirin is just a model, the results confirm the usefulness of CaP coating in 
moduating drug release. 
 
 
 
 
Fig. 64 - XRPD pattern of CaP coated aspirin loaded gelatin microspheres. 
 
 
 
 
 
Fig. 65 - SEM images of CaP coated aspirin loaded microspheres: a particular of 
CaP shell (scale bar = 1	m). 
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Fig. 66 - Percentage of aspirin released from uncoated (pink squares) and coated  
(green squares) microspheres. 
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6. Conclusions 
 
The results achieved during this PhD thesis put into evidence the role of several 
biologically active ions and molecules on the synthesis and relative stability of a few 
calcium phosphates widely employed in the field of biomaterials for hard tissue repair, 
namely HA, OCP, -TCP. A wide part of the investigation was addressed to study the 
interaction of CaPs with Sr2+ ion, which is known to play an active role on bone 
resorption and formation. 
Ca–Sr–HA solid solutions have been prepared in the whole range of composition by 
the direct synthesis in aqueous solution with a degree of crystallinity sufficient to allow 
a structural analysis of the isomorphous compounds without further heat treatment. 
Increasing strontium substitution for calcium in the HA structure provokes a linear 
variation of the cell parameters and of the infrared absorption bands, in agreement with 
the increasing mean dimensions of the cation. At variance, the effect of strontium on 
crystallinity and morphology changes with composition: relatively low Sr replacement 
to calcium induces a decrease of the coherent length of the perfect crystalline domains 
and disturbs the shape of the crystals, whereas crystallinity, as well as mean dimensions 
of the crystals, increases at relatively high strontium contents. Similarly, although 
strontium distribution is not deeply different in the two cationic sites, a slight Sr 
enrichment of M(2) site prevails in most of the range of composition, whereas a modest 
preference of Sr for the smaller M(1) site can be appreciated only at a very low 
strontium content. This result, which is opposite to what was expected on the basis of 
the difference in ionic radii, is of peculiar importance for it concerns a composition in 
the range of strontium concentration in the bone. 
The results of the in vitro study carried out on cultures of bone cells grown on HA 
nanocrystals containing up to 7% Sr indicate that this ion stimulate osteoblast activity 
and exerts its inhibitory effect on osteoclast proliferation even when incorporated into 
hydroxyapatite.  
On the basis of those positive results, Pulsed Laser Deposition was successfully 
applied to deposit thin films of Sr substituted HA on titanium substrates. The 
synthesized coatings displayed a uniform Sr distribution, a granular surface and a good 
degree of crystallinity which slightly decreased on increasing Sr content. The results of 
in vitro tests suggested that the presence of Sr in HA thin films can enhance the positive 
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effect of HA coatings on osteointegration and bone regeneration, and prevent 
undesirable bone resorption. 
At variance with the behaviour of Sr towards HA, this ion inhibits the synthesis of 
OCP. As a matter of fact, the presence of Sr in the synthesis reaction promotes the 
precipitation of DCPD, and OCP can be obtained as unique crystalline phase just when 
the synthesis is performed at 70°C in the presence of Sr2+ concentration up to 15 atom 
%. However, in this range of concentration, Sr enters the lattice structure of OCP, in 
agreement with the increase of the cell parameters observed on increasing ion 
concentration. 
A similar behaviour was recorded for Mg2+ ions which provokes a reduction of the 
unit cell in agreement with it smaller ionic radius. The relative amount of magnesium 
that can substitute for calcium in OCP structure most likely is slightly less than that 
achievable in the case of Sr, as suggested by the minor variation of the unit cell volume. 
These results are of peculiar importance since Sr-substituted OCP as well as Mg-
substituted OCP, couple the osteogenetic properties of octacalcium phosphate, with the 
biologically relevant properties of Sr and Mg, which could be successfully exploited in 
the preparation of calcium phosphate based biomaterials. At variance, Mn2+ ion 
completely inhibits the synthesis of OCP, whereas it promotes the precipitation of 
DCPD. Further investigations could clarify if these ions are incorporated into the 
structure of DCPD, or simply adsorbed on crystal surface.  
Sr2+ ion exerts an active role also in the hydrolysis of -TCP: in the presence of 
increasing amounts of Sr2+ in solution, the speed of the conversion reaction of -TCP 
into HA is highly reduced even in the presence of DCPD, which accelerates the 
hydrolysis reaction. However, the resulting apatitic phase contains significant amounts 
of Sr2+ suggesting that the addition of Sr2+ to the composition of -TCP bone cements 
could be successfully exploited for its local delivery in bone defects. 
The results obtained in the presence of gelatin indicate that it accelerates the 
hydrolysis reaction with a catalytic effect even greater than that of DCPD. Moreover, 
the acidic character of gelatin solution promotes the conversion of -TCP into OCP, so 
that at relatively high gelatin concentration, the reaction product consists of a mixture of 
OCP and HA. It is conceivable to suppose that the use of gelatin in the composition of 
-TCP based CPCs would not only accelerate the hardening reaction and provide a 
material more close to bone composition, but also lead to a fast resorption and new bone 
formation thank to the presence of OCP.  
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The work performed during this PhD thesis allowed, furthermore, to optimize the 
experimental conditions to cover gelatin microspheres with an uniform layer of calcium 
phosphate in order to obtain useful materials for modulated drug delivery and release. 
The microspheres have been charged with a model drug (aspirin) to investigate the 
kinetics of its release from uncoated and coated microspheres. The results indicate that 
the presence of a calcium phosphate coating of the microspheres delays the release of 
aspirin thus allowing to modulate its action. 
The possibility to introduce an active molecule in the implant site has been explored 
using MAPLE to deposit alendronate-hydroxyapatite nanocrystals at different 
bisphosphonate content. The mild conditions of work of this innovative technique do 
not affect the molecule of alendronate, which might be decomposed by the traditional 
PLD. As a matter of fact, MAPLE has been successfully employed to deposit thin films 
of HA at increasing alendronate content. The coatings exhibit a good degree of 
crystallinity and a positive effect on cell activity and proliferation. Osteoblast MG-63 
cells cultured on the coatings displayed increased proliferation and increased values of 
collagen type I and osteocalcin expression on increasing alendronate content. These 
results indicate that it is possible to use MAPLE technique to synthesize coatings which 
combine the bioactivity of hydroxyapatite with the local availability of alendronate. 
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